Dr.HeidiM.Mansour: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(628 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Contact Info==
'''Shalom Aleichem. Numen Lumen. Sursum. Lux libertas. Carpe Diem.
Dr. Heidi M. Mansour, Ph.D., R.Ph.
Assistant Professor of Pharmaceutics & Drug Delivery,
Faculty Associate in the UK Center of Membrane Sciences,
UK College of Pharmacy
Dept of Pharmaceutical Sciences-Drug Development
789 South Limestone St., Office 331,
Lexington, Kentucky 40536-0596


Telephone: (859) 257-1571; Email: heidi.mansour@uky.edu
 
[[Image:Brewers.jpg‎ |200px]]
<div style="padding: 10px; color: #ffffff; background-color: #000; width: 750px">
<center>
 
[[Mansour Lab | <font face="trebuchet ms" style="color:#ffffff"> '''Home''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Current Lab Members | <font face="trebuchet ms" style="color:#ffffff"> '''Current Lab Members''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Past Lab Members & Current Positions | <font face="trebuchet ms" style="color:#ffffff"> '''Past Lab Members & Current Positions''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Journal Publications | <font face="trebuchet ms" style="color:#ffffff"> '''Journal Publications''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Book Chapters | <font face="trebuchet ms" style="color:#ffffff"> '''Book Chapters''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Edited Book | <font face="trebuchet ms" style="color:#ffffff"> '''Edited Book''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Invited Talks | <font face="trebuchet ms" style="color:#ffffff"> '''Invited Talks''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Research Support | <font face="trebuchet ms" style="color:#ffffff"> '''Research Support''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</center>
</div><br>
 
 
=="The Leading Research University in the American Southwest" "Sursum"==
 
[[Image:UA.jpg |500px]]
 
Dr. Heidi M. Mansour <BR>
The University of Arizona<BR>
College of Pharmacy & The BIO5 Research Institute<BR>
1703 E. Mabel St.<BR>
Office 434/Lab 435 Skaggs Pharmaceutical Sciences Center<BR>
Tucson, AZ 85721-0202. <BR>
 
Email: mansour@pharmacy.arizona.edu<BR>
Office Telephone: (520) 626-2768<BR>
Lab Telephone:(520) 626-3232
 
[[Image:COP_Skaggs.jpg‎ |100px]]


== Websites ==
== Websites ==
1. http://pharmacy.mc.uky.edu/faculty/HeidiMansour.php


2.http://www.linkedin.com/in/heidimansour
Research & Education: [http://www.pharmacy.arizona.edu/directory/heidi-mansour-phd]
 
Graduate College Faculty Member:[http://graduate.pharmacy.arizona.edu/content/faculty-2]
 
Faculty Member, The BIO5 Research Institute: [http://www.bio5.org/]
 
Affiliated Faculty Member, Institute of the Environment: [http://environment.arizona.edu/heidi-mansour]
 
Associate Member [http://azcc.arizona.edu/profile/heidi-mansour], NCI Comprehensive Cancer Center: [http://azcc.arizona.edu/about]
 
Google Scholar Publications: [http://scholar.google.com/citations?hl=en&user=w2MFixQAAAAJ&sortby=pubdate&view_op=list_works&pagesize=100]
PubMed Publications: [http://www.ncbi.nlm.nih.gov/pubmed/?term=mansour+hm]
LinkedIn Profile: [http://www.linkedin.com/in/heidimansour]
Research Gate Profile: [https://www.researchgate.net/profile/Heidi_Mansour/info/?ev=prf_info]
 
College of Pharmacy:
http://www.pharmacy.arizona.edu/visitors/college-of-pharmacy-facts
 
World Rankings in Pharmacy & Pharmacology (Global):
http://www.topuniversities.com/university-rankings/university-subject-rankings/2014/pharmacy#sorting=rank+region=+country=+faculty=+stars=false+search=
 
World Rankings in Pharmacy & Pharmacology (USA):http://www.topuniversities.com/university-rankings/university-subject-rankings/2014/pharmacy#sorting=rank+region=+country=257+faculty=+stars=false+search=
 
The University of Arizona:
http://www.arizona.edu/about/highlights-rankings
 
The University of Arizona Medical Center:
http://uanews.org/story/university-of-arizona-medical-center-again-a-u-s-news-best-hospital
 
==Professor Mansour Links==
1. University of Wisconsin-Madison, Dept. of Hebrew & Semitic Studies: [http://www.secfac.wisc.edu/senate/2002/0204/1606(mem_res).pdf]  [http://ancienthebrewpoetry.typepad.com/ancient_hebrew_poetry/2008/02/how-well-do-you.html]
 
2. Tel Aviv University: [http://www.cs.tau.ac.il/~mansour/bio.htm] [http://www.tau.ac.il/~mansour/CV_Yishay_Mansour.htm]
 
3. Harvard Medical School: [http://www.massgeneral.org/heartcenter/doctors/doctor.aspx?ID=17326]
 
4. Stanford University School of Medicine, Molecular Pharmacology: [http://med.stanford.edu/news/all-news/2011/11/stanford-pharmacology-leader-tag-mansour-dies-at-86.html] [http://www.paloaltoonline.com/obituaries/memorials/tag-eldin-mansour?o=1536]


==Editorial Advisory Board Member (EAB)==
5. Emory University School of Medicine: [http://www.surgery.emory.edu/about-us/faculty_directory/faculty_profile_kamal_mansour.html]
1. Pharmaceutical Technology North America[http://pharmtech.findpharma.com/eab]


2. Journal of Nanomedicine & Nanotechnology [http://www.omicsonline.org/EditorialboardJNMNT.php]
6. University of Texas Southwestern Medical Center: [http://profiles.utsouthwestern.edu/profile/95877/john-mansour.html]


3. Journal of Nanotechnology & Biotherapeutic Discovery [http://www.omicsonline.org/EditorialboardJNBD.php]
7. Case Western Reserve  University School of Engineering: [http://engineering.case.edu/emae/Faculty/Joseph_Mansour]


4. Recent Patents on Nanomedicine [http://www.benthamscience.com/nanom/EBM.htm]
8. University of Colorado-Denver:[http://www.ucdenver.edu/academics/colleges/CLAS/Departments/economics/Faculty/tenure-track/Pages/HaniMansour.aspx][http://econ.ucdenver.edu/mansour/]


5. Recent Patents on Drug Delivery & Formulation [http://www.bentham.org/ddf/EBM.htm]
9.University of Utah, Dept. of Molecular Biology & Human Genetics: [http://www.bioscience.utah.edu/faculty/molecular-biology-faculty/mansour/mansour.php] [http://www.genetics.utah.edu/?page_id=707]


6. Medicinal Chemistry: Current Research [http://www.omicsonline.org/editorialboardMCCR.php]
10.The University of Texas: [https://med.uth.edu/ortho/faculty/alfred-mansour/]


7. Journal of Pharmaceutical Technology & Drug Research (United Kingdom) [http://www.hoajonline.com/Journal-of-Pharmaceutical-Technology-and-Drug.html]
==Education==


8. International Journal of Nano-Studies & Technology [http://www.scidoc.org/editorial_board.php?id=3]
Postdoctorate, University of North Carolina-Chapel Hill[http://unc.edu/], School of Pharmacy[https://pharmacy.unc.edu/news/schoolnews/mansour-earns-three-postdoctoral-awards], 1/2006-6/2008.<BR>
[[Image:UNC-chapel-hill.jpg.png|200px]] [[Image:Unc_seal.jpg|80px]]  


9. Journal of Molecular Pharmaceutics and Organic Process Research [http://www.esciencecentral.org/journals/editorialboardJMPOPR.php]
Postdoctorate, University of Wisconsin-Madison[http://www.wisc.edu/], School of Pharmacy[http://www.pharmacy.wisc.edu/newsletter/may2013][http://www.pharmacy.wisc.edu/newsletter/july2013], 2004.<BR>
[[Image:UW.jpg|100px]] [[Image:Forward badger.jpg|100px]]


==National Expert Committees==
Ph.D. Major-Pharmaceutical Sciences (Pharmaceutics & Drug Delivery), University of Wisconsin-Madison, School of Pharmacy, 12/2003.<BR>
1. United States Pharmacopeia Delegate [http://www.usp.org/pdf/EN/members/2010-Delegates-and-Alternates.pdf]
Ph.D. Minor-Advanced Physical & Biophysical Interfacial Chemistry, University of Wisconsin-Madison, Department of Chemistry, 12/1999.<BR>
[[Image:IMG_0725.JPG|100px]] [[Image:Siftwinnow.jpg|100px]]  


2. NIH/NICHD U.S. Pediatric Formulations Initiative (PFI) New Drug Delivery Systems (NDDS) Working Group-Aerosols
B.S.-Pharmacy (Distinction & Honors), University of Wisconsin-Madison, 5/1996. <BR>
[[Image:UW_SOP.png|100px]] [[Image:Numen_Lumen.png|80px]]


== Book Proposal Publisher Reviewer ==
==Health Professional Licensure==
1.Springer Publisher


2.Marcel-Dekkar Publisher
Registered Pharmacist 8/1996-Present. <BR>
[[Image:Rx_snake.png|70px]]  [[Image:Bucky_Badger_RPh.jpg|80px]]


3.Elsevier Publisher
==Research Program==
Research in the Mansour lab focuses on the fundamental and applied aspects of surface and interfacial chemistry, nanotechnology, and particle engineering technologies in the design and optimization of advanced drug delivery systems.  Multifunctional polymeric phospholipid (lipopolymeric) self-assemblies are optimized for targeted drug delivery, nanomedicine, and multifunctional microparticles and nanoparticles in the solid-state as dry powder inhalation aerosols in the targeted treatment and prevention of several pulmonary diseases. These microparticulate/nanoparticulate dry powders which are targeted directly to the lung as dry powder inhalers are biocompatible, biodegradable, mucopenetrating, and provide sustained drug release. We utilize various types of inhaler devices for both ''in vitro'' and ''in vivo'' rodent animal models. A systematic Quality-by-Design (QbD) approach in the solid-state is used and includes comprehensive physicochemical characterization, design of experiments (DOEs), performance modeling, and prediction.  Pulmonary diseases with unmet medical needs that we investigate ''in vitro'' and ''in vivo'' include lung transplantation, lung cancer, infectious diseases, lung inflammatory fibrotic diseases, and autoimmune diseases. Our research program includes translational medicine, as exemplified by several successful collaborations with physician-scientists.


4.Wiley-Interscience Publisher
==Editorial Advisory Board Member (EAB)& Scientific Advisor==
1. Pharmaceutical Technology North America[http://www.pharmtech.com/pharmtech-editorial-advisory-board]


5.Pharmaceutical Press-The Royal Pharmaceutical Society of Great Britain
2. Recent Patents on Nanomedicine [http://www.benthamscience.com/nanom/EBM.htm]
 
3. Journal of Pharmaceutical Technology & Drug Research (United Kingdom) [http://www.hoajonline.com/Journal-of-Pharmaceutical-Technology-and-Drug.html]
 
4. Journal of Pharmaceutical Sciences-Scientific Advisor to the Editors [http://mc.manuscriptcentral.com/societyimages/jpharmsci/List%20of%20Scientific%20Advisor%20Keyword%20List.xlsx] [http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1520-6017/homepage/EditorialBoard.html]
 
==National Expert Committees & Study Sections==
1. NIH/NICHD U.S. Pediatric Formulations Initiative (PFI) New Drug Delivery Systems (NDDS) Working Group<BR>
[[Image:NICHD.jpg|250px]]
 
2. NIH/NIAID<BR>
[[Image:NIAID.jpg‎|450px]]
 
3. NIH/NCI<BR>
[[Image:NCI.png‎|450px]]
 
4. American Association for the Advancement of Science (AAAS)<BR>
[[Image:AAAS.jpg|200px]]
 
==International Expert Committees==
1. Indo-US Science & Technology
 
2. Austrian Science Fund
 
3. German-Israeli Foundation (GIF) for Scientific Research and Development
 
4. Deutscher Akademischer Austauschdienst Dienst (DAAD)German International Academic Exchange Service
 
5. Catalent Applied Drug Delivery Institute


== Honors & Awards ==
== Honors & Awards ==
* 2010, Mercer School of Pharmacy Dept of Pharmaceutical Sciences, Pharmabeat 2010 Researcher of the Issue, Mercer University
* 2010, Mercer School of Pharmacy Dept of Pharmaceutical Sciences, Pharmabeat 2010 Researcher of the Issue, Mercer University
* 2010, Scholarship of Teaching & Learning Certificate (STLC) Award, UK College of Pharmacy, University of Kentucky
* 2007, NIH Regional Training Award Scholar, National Institutes of Health (NIH)/UNC-Chapel Hill
* 2007-2008, Post Doctoral Fellow Award in Pharmaceutics, PhRMA Foundation
* 2007-2008, Post Doctoral Fellow Award in Pharmaceutics, PhRMA Foundation
* 2007-2008, Post Doctoral Scholars Award for Research Excellence, Office of the Vice Chancellor, University of North Carolina at Chapel Hill
* 2007-2008, Post Doctoral Scholars Award for Research Excellence, Office of the Vice Chancellor, University of North Carolina at Chapel Hill
Line 69: Line 160:
* 1991, Elected Member, Phi Eta Sigma National Honor Society
* 1991, Elected Member, Phi Eta Sigma National Honor Society
* 1991, Elected Member, Phi Kappa Phi National Honor Society
* 1991, Elected Member, Phi Kappa Phi National Honor Society
* 1991, Elected Member, Golden Key International Honor Society  
* 1991, Elected Member, Golden Key International Honor Society
 
==Research Support==
 
[[Image:FDA.jpg‎ |200px]]        [[Image:NIH.jpg |120px]]    <BR>
 
[[Image:NIAID.jpg‎|500px]]  <BR>
 
[[Image:OSUCOMLogo.png|450px]] <BR>
 
[[Image:NCH.jpg|300px]] <BR>
 
[[Image:JHU.png|250px]] <BR>
 
[[Image:NCI.png‎|500px]] <BR>
 
[[Image:Sungkyunkwan.png |150px]]
 
[[Image:Cureveda.jpg|250px]] [[Image:GSK.png |200px]] [[Image:Buchi.jpg |150px]] [[Image:Oakwood.png |200px]] [[Image:Pfizer.jpg |150px]] [[Image:BI.jpg |200px]]


==Invited Speaker (2005-Present)==
==Invited Speaker (2005-Present)==
Line 92: Line 201:
8. International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on ''“Imaging of Drugs and Dosage Forms to Better Understand Dissolution”''. Invited Speaker. Presentation Title: ''"Imaging Techniques for Designed Microparticulate/Nanoparticulate Pharmaceutical Powders".'' 2011.
8. International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on ''“Imaging of Drugs and Dosage Forms to Better Understand Dissolution”''. Invited Speaker. Presentation Title: ''"Imaging Techniques for Designed Microparticulate/Nanoparticulate Pharmaceutical Powders".'' 2011.


9. American Chemical Society (ACS) 242nd Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry-Symposium on ''“Nanomedicine: Colloids & Surface Science”''. Denver, CO. Symposium Session Chair Presider & Invited Symposium Speaker. Presentation Title: ''"Rational Design, Development, and Optimization of Nanopharmaceuticals for Targeted Drug Delivery in Nanomedicine: An Interfacial and Colloidal Science Approach”.'' 2011.
9. American Chemical Society (ACS) 242nd Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry-Symposium on ''“Nanomedicine: Colloids & Surface Science”''. Denver, CO.  
 
Symposium Session Chair Presider [http://acselb-529643017.us-west-2.elb.amazonaws.com/chem/242nm/program/divisionindex.php?act=presentations&val=Nanomedicine:+Colloid+and+Surface+Science&ses=Nanomedicine:+Colloid+and+Surface+Science&prog=62147]
 
Invited Symposium SpeakerPresentation Title: ''"Rational Design, Development, and Optimization of Nanopharmaceuticals for Targeted Drug Delivery in Nanomedicine: An Interfacial and Colloidal Science Approach”.'' 2011.[http://acselb-529643017.us-west-2.elb.amazonaws.com/chem/242nm/program/divisionindex.php?act=presentations&val=Nanomedicine:+Colloid+and+Surface+Science&ses=Nanomedicine:+Colloid+and+Surface+Science&prog=62147]


10. 4th Annual AAPS Nanotechnology & Nanomedicine Symposium, Louisville, KY. Invited Speaker. Presentation Title: ''"Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Aerosol Delivery.''" 2011.
10. 4th Annual AAPS Nanotechnology & Nanomedicine Symposium, Louisville, KY. Invited Speaker. Presentation Title: ''"Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Aerosol Delivery.''" 2011.
Line 104: Line 217:
14.Transcept Pharmaceuticals. Invited Webinar Speaker. Presentation Title: ''"Fundamental and Applied Aspects of Sustained Release Injectible Depot Delivery''". 2012.
14.Transcept Pharmaceuticals. Invited Webinar Speaker. Presentation Title: ''"Fundamental and Applied Aspects of Sustained Release Injectible Depot Delivery''". 2012.


15. Buchi Annual Spray Drying Short-Course, Buchi U.S. Headquarters. New Castle, DE. Invited Speaker/Short-Course Instructor. Presentation Title: ''"Engineering Particles by Advanced Organic Solution Spray Drying for Nanopharmaceuticals and Targeted Pulmonary Inhalation Aerosol Delivery.''" 2012. [http://www.mybuchi.com/Agenda.33805.0.html]
15. Buchi Hands-On Spray Drying Course, Buchi U.S. Headquarters. New Castle, DE. Invited Speaker. Presentation Title: ''"Engineering Particles by Advanced Organic Solution Spray Drying for Nanopharmaceuticals and Targeted Pulmonary Inhalation Aerosol Delivery.''" 2012. [http://www.niroinc.com/pdfs/news/spray_drying_course_flyer_2012.pdf]


16. Lovelace Respiratory Research Institute (LRRI). Albuquerque, NM. Invited Speaker in the LRRI and CNTC Seminar Series. Presentation Title:''"Advances in Targeted Lung Nanomedicine as Aerosolized Multifunctional Microparticles and Nanoparticles for Pulmonary Disease Treatment and Prevention.''"  2012. [http://cntc.unm.edu/news.html]
16. Lovelace Respiratory Research Institute (LRRI). Albuquerque, NM. Invited Speaker in the LRRI and CNTC Seminar Series. Presentation Title:''"Advances in Targeted Lung Nanomedicine as Aerosolized Multifunctional Microparticles and Nanoparticles for Pulmonary Disease Treatment and Prevention.''"  2012. [http://cntc.unm.edu/news.html]
Line 116: Line 229:
20. North American Cystic Fibrosis Conference (NACFC), Orlando, FL.  Invited Symposium Speaker. NACFC Aerosol Symposium: ''"Aerosol Treatments in CF: Clearing the Fog."'' Presentation Title: ''"Aerosol Formulation Issues."'' 2012.[http://www.softconference.com/nacfc/sessionDetail.asp?SID=293839]
20. North American Cystic Fibrosis Conference (NACFC), Orlando, FL.  Invited Symposium Speaker. NACFC Aerosol Symposium: ''"Aerosol Treatments in CF: Clearing the Fog."'' Presentation Title: ''"Aerosol Formulation Issues."'' 2012.[http://www.softconference.com/nacfc/sessionDetail.asp?SID=293839]


21. 19th Congress of the International Society of Aerosols in Medicine (ISAM), Chapel Hill, NC. Invited Speaker. ISAM Workshop: ''"Nanomedicine & Nanotoxicology: Inhaling nanoparticles by accident and on purpose-challenges and opportunities for toxicology and therapeutics''" 2013.
21. 19th World Congress of the International Society of Aerosols in Medicine (ISAM), Chapel Hill, NC. Invited Speaker. ISAM Workshop: ''"Nanomedicine & Nanotoxicology: Inhaling nanoparticles by accident and on purpose-challenges and opportunities for toxicology and therapeutics.''" Presentation Title: ''"Nanotechnology in Dry Powder Inhalation Aerosol Formulations."'' 2013.[http://www.med.unc.edu/isam2013/files/isam2013-inhaling-nanoparticles-by-accident-and-on-purpose-challenges-and-opportunities-for-toxicology-and-therapeutics-1]


'''''Local Invited Speaker Presentations'''''
22. AAPS/USP/FDA/IPAC Workshop on Inhaled Drug Products, United States Pharmacopeia (USP), Rockville, MD. Invited Speaker. ''"Inhaled Drug Products: Current Practices and the Future of In Vitro Testing Technologies and Regulation.''" Presentation Title: ''"Solid-State Characterization and Nanotechnology in Inhalation Aerosol Formulation Development."'' 2013. [http://www.aaps.org/Meetings_and_Professional_Development/Conference_Mini_Sites/AAPS_Workshop_on_Inhaled_Drug_Products/Program/]


1.PEPSIG, UK COP & UK Engineering, Lexington, KY. 2008.
23. Association of Inhalation Toxicologists (AIT) Annual Conference, Hannover, Germany. Invited Speaker. Session: ''"Nanomaterials.''" Presentation Title: ''"Nanomaterials as an Aerosol Formulation Carrier in Inhalation Aerosol Nanomedicine.''" 2013. [http://www.aitox.org/events.html]


2.International Society of Pharmaceutical Engineers (ISPE), UK College of Engineering, Lexington, KY. Invited Speaker. 2009.
24. Eastern Analytical Symposium & Exhibition (EAS), Somerset, NJ. Invited Speaker. Coblentz EAS Session: ''"Spectroscopic Applications in Biologics.''" Presentation Title:''"Characterization and Spectroscopic Applications in Pulmonary Delivery and Advanced Dry Powder Inhalers."'' 2013. [http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&ved=0CDAQFjAA&url=http%3A%2F%2Feasinc.org%2Fwordpress%2Fwp-content%2Fuploads%2F2013%2F04%2FInvited-Sessions-Retort-13-web.pdf&ei=VoyCUeKwDNG90QGh14GoBA&usg=AFQjCNHd1WIxlTFWwyTfKeL2VfTuSfK5FA&sig2=A8ZIGQZUAAcng7OImT7dqA&bvm=bv.45921128,d.dmQ] [http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&ved=0CDYQFjAB&url=http%3A%2F%2Feasinc.org%2Fwordpress%2Fwp-content%2Fuploads%2F2013%2F04%2FEAS-April-Retort-2013-final1.pdf&ei=VoyCUeKwDNG90QGh14GoBA&usg=AFQjCNGelg8XbLU_hEjKQSfljVJUd5pUkw&sig2=UNYlvhfPSxucRKODNoIRzg&bvm=bv.45921128,d.dmQ]


3.UK College of Medicine-Pulmonary Medicine Division/Pediatric Research Group Seminar. 2009.
25.Buchi Hands-On Spray Drying Course, Newark, DE. Invited Speaker Presentation: ''"Designing High Performing Microparticulate/Nanoparticulate Dry Powder Inhalers by Organic Solution Advanced Spray Drying.''" 2014. [http://www.buchi.com/en/node/1689]


4.UK College of Engineering-NSF REU Faculty Panel Speaker, Lexington, KY. 2009.
26.American Chemical Society (ACS) 249th Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry Symposium, Denver, CO. Invited Symposium Presentation: ''"Advances in Targeted Multifunctional Inhalation Aerosols with Nanotechnology and Solid-State Particle Engineering Design."'' 2015.


5.UK Lung Biology Group & UK Pulmonary Medicine Research Conference Seminar,College of Medicine-Pulmonary Medicine Division, Lexington, KY. 2009.
27. American Thoracic Society (ATS) International Conference joint with ISAM, Denver, CO. ATS/ISAM Presentation: ''"Multifunctional Nanotechnology in Lung Surfactant-Mimic Inhalation Aerosols as High-Performing Dry Powder Inhalers for Targeted Pulmonary Medicine."'' 2015.
6.UK Center of Membrane Sciences Faculty Associates Research Symposium, Lexington, KY. 2009.


7.UK Dept of Biomedical Engineering Seminar Series, Lexington,KY.  
28. Inhalation Magazine Annual Webinar joint with CSC Publishing and MSP Corporation. Invited Presentation: ''"Inhalation Pharmaceuticals: Device Design and Formulations."'' 2015.
Invited Speaker. Presentation Title: ''"Advances in Sustained-Release Injectable Depot Drug Delivery and Controlled Release Pulmonary Inhalation Aerosol Drug Delivery"'' 2010.


8.International Society of Pharmaceutical Engineers(ISPE), Lexington, KY.
29. Controlled Release Society (CRS) 42nd Annual Meeting & Exhibition. Edinburgh, Scotland, Great Britain. CRS Workshop Co-Chair & Invited Speaker. CRS Workshop: ''"Advanced Pulmonary Drug Delivery: From Generating Aerosols to Overcoming Biological Barriers.''" 2015.[http://www.controlledreleasesociety.org/meetings/annual/program/Pages/PulmonaryWorkshop.aspx]
Invited Speaker. Presentation Title: ''"Targeted Pulmonary Dry Powder Inhalation Aerosols: Pulmonary Infection Drug Delivery & Non-Invasive Needle-Free Pulmonary Vaccines".'' 2010.


9. "Hanging with Zwisch" Research Colloquium, UK College of Medicine-Dept of Pulmonary & Surgery. Lexington, KY. Invited Speaker.
30. Antibiotic resistance and antibiotic alternatives: Looking towards the future, London, England. Invited Speaker Presentation: ''"Targeted Pulmonary Delivery of Antibiotics by Multifunctional Dry Powder Inhalation Aerosols and Nanotechnology for Pulmonary Infectious Diseases."'' 2015. [http://www.rsc.org/events/detail/17560/antibiotic-resistance-and-antibiotic-alternatives-looking-towards-the-future]
Presentation Title : ''"Advances in Targeted Lung Delivery as Inhaled Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention”.'' 2011.
 
10. International Society of Pharmaceutical Engineers(ISPE). Invited Speaker. Presentation Title: ''"Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention.''" 2012.
 
11. First Annual Makenna Foundation Symposium on Pediatric Pulmonary Disease, Lexington, KY. Invited Panel Speaker. Presentation Title: ''"Biomedical Aerosol Engineering and Pulmonary Nanomedicine in Cystic Fibrosis Treatment & Lung Transplant Immunosuppression.''" 2012.[http://www.cecentral.com/live/5514/faculty]


==Short-Course/Workshop Instructor==
==Short-Course/Workshop Instructor==
1.Aerosol School 2-Day Workshop: ''"Aerosol Science Fundamentals and Inhalation Aerosol Delivery''", NIH-NCI Cancer Nanotechnology Training Center (CNTC),  April 17-18 2012.
1.Aerosol School 2-Day Workshop: ''"Aerosol Science Fundamentals and Inhalation Aerosol Delivery''", NIH-NCI Cancer Nanotechnology Training Center (CNTC),  April 17-18 2012.


==Journal Publications *Corresponding Author* ==
==Journal Publications==
1. '''Mansour H.''', Wang D.-S., Chen C.-S., and Zografi G. ''Comparison of Bilayer and Monolayer Properties of Phospholipid Systems Containing Dipalmitoylphosphatidylglycerol and Dipalmitoylphosphatidylinositol.'' [[Langmuir]] (2001) 17 (21) October 16: 6622-6632. (Impact Factor: 4.186)[http://pubs.acs.org/doi/abs/10.1021/la0108454]


2. '''*Mansour, H.M.*''' and Zografi G. ''The Relationship Between Water Vapor Absorption and Desorption by Phospholipids and Bilayer Phase Transitions.'' [[Journal of Pharmaceutical Sciences]] (2007) 96 (2) February: 377-396. (Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20810/abstract]


3. '''*Mansour, H.M.*''' and Zografi G. ''Relationships Between Equilibrium Spreading Pressure and Phase Equilibria of Phospholipid Bilayers  and Monolayers at the Air-Water Interface.'' [[Langmuir]] (2007) 23 (7) March 27: 3809-3819. (Impact Factor: 4.186)[http://pubs.acs.org/doi/abs/10.1021/la063053o]
'''== 2001-2009 =='''


4. '''*Mansour H.M.*''', Damodaran S., and Zografi G.'' Characterization of the In Situ Structural and Interfacial Properties of the Cationic Hydrophobic Heteropolypeptide, KL4, in Lung Surfactant Bilayer and Monolayer Models at the Air-Water Interface: Implications for Pulmonary Surfactant Delivery.'' [[Molecular Pharmaceutics]] (2008) 5 (5) October 6: 681-695. (Impact Factor: 4.782)[http://pubs.acs.org/doi/abs/10.1021/mp700123p]
1. '''Mansour H.''', Wang D.-S., Chen C.-S., and Zografi G. ''Comparison of Bilayer and Monolayer Properties of Phospholipid Systems Containing Dipalmitoylphosphatidylglycerol and Dipalmitoylphosphatidylinositol.'' [[Langmuir]] (2001) 17 (21) October 16: 6622-6632. (Impact Factor: 4.384)[http://pubs.acs.org/doi/abs/10.1021/la0108454]


5. Hickey, A.J., '''Mansour, H.M.''', et al. ''Physical Characterization of Component Particles Included in Dry Powder Inhalers: I. Strategy Review and Static Characteristics.'' [[Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue]] (2007) 96 (5) May: 1282-1301. (Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20916/pdf]
2. '''Mansour, H.M.''' and Zografi G. ''The Relationship Between Water Vapor Absorption and Desorption by Phospholipids and Bilayer Phase Transitions.'' [[Journal of Pharmaceutical Sciences]] (2007) 96 (2) February: 377-396. (Impact Factor: 3.007)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20810/abstract]


6. Hickey, A.J., '''Mansour, H.M.''', et al. ''Physical Characterization of Component Particles Included in Dry Powder Inhalers: II. Dynamic Characteristics.'' [[Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue]] (2007) 96 (5) May: 1302-1319. (Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20943/pdf]
3. '''Mansour, H.M.''' and Zografi G. ''Relationships Between Equilibrium Spreading Pressure and Phase Equilibria of Phospholipid Bilayers  and Monolayers at the Air-Water Interface.'' [[Langmuir]] (2007) 23 (7) March 27: 3809-3819. (Impact Factor: 4.384)[http://pubs.acs.org/doi/abs/10.1021/la063053o]


7. '''*Mansour, H.M.*''' and Hickey, A.J. ''Raman Characterization and Chemical Imaging of Biocolloidal Self-Assemblies, Drug Delivery Systems, and Pulmonary Inhalation Aerosols. A Review.'' [[AAPS PharmSciTech]] (2007) 8 (4) November 30: Article 99:E1-E16. (Impact Factor: 1.445)[http://www.springerlink.com/content/q457w76780538w54/]
4. Hickey, A.J., '''Mansour, H.M.''', et al. ''Physical Characterization of Component Particles Included in Dry Powder Inhalers: I. Strategy Review and Static Characteristics.'' [[Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue]] (2007) 96 (5) May: 1282-1301. (Impact Factor: 3.007)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20916/pdf]


8. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Comparative Dispersion Study of Dry Powder Aerosols of Albuterol Sulfate/Lactose Monohydrate and Cromolyn Sodium/Lactose Monohydrate Delivered by Standardized Entrainment Tubes.'' [[Respiratory Drug Delivery]] (2008) 3: 897-900. [http://www.rddonline.com/publications/articles/article.php?ArticleID=1265&return=1]
5. Hickey, A.J., '''Mansour, H.M.''', et al. ''Physical Characterization of Component Particles Included in Dry Powder Inhalers: II. Dynamic Characteristics.'' [[Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue]] (2007) 96 (5) May: 1302-1319. (Impact Factor: 3.007)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20943/pdf]


9. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 1. Albuterol Sulfate and Disodium Cromoglycate.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 2: 3398-3414.(Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22107/abstract]
6. '''Mansour, H.M.''' and Hickey, A.J. ''Raman Characterization and Chemical Imaging of Biocolloidal Self-Assemblies, Drug Delivery Systems, and Pulmonary Inhalation Aerosols. A Review.'' [[AAPS PharmSciTech]] (2007) 8 (4) November 30: Article 99:E1-E16. (Impact Factor: 1.776)[http://www.springerlink.com/content/q457w76780538w54/]


10. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 10: 3415-3429. (Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22100/abstract]
7. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Comparative Dispersion Study of Dry Powder Aerosols of Albuterol Sulfate/Lactose Monohydrate and Cromolyn Sodium/Lactose Monohydrate Delivered by Standardized Entrainment Tubes.'' [[Respiratory Drug Delivery]] (2008) 3: 897-900. [http://www.rddonline.com/publications/articles/article.php?ArticleID=1265&return=1]


11. '''Mansour, H.M.''', Xu, Z., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Alternative Sugar Blends: 3. Trehalose Dihydrate and D-Mannitol Carriers.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March12; 3430-3441.(Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22101/abstract]
8. '''Mansour H.M.''', Damodaran S., and Zografi G.'' Characterization of the In Situ Structural and Interfacial Properties of the Cationic Hydrophobic Heteropolypeptide, KL4, in Lung Surfactant Bilayer and Monolayer Models at the Air-Water Interface: Implications for Pulmonary Surfactant Delivery.'' [[Molecular Pharmaceutics]] (2008) 5 (5) October 6: 681-695. (Impact Factor: 4.787)[http://pubs.acs.org/doi/abs/10.1021/mp700123p]


12. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Heterogenous Particle Deaggregation and Its Implications for Therapeutic Aerosol Performance.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 15: 3442-3461.(Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22057/abstract]
9. '''Mansour, H.M.''', Rhee, Y.S., and Wu, X. ''Nanomedicine in Pulmonary Delivery.'' [[International Journal of Nanomedicine]] (2009) 4 December: 299-319.(Impact Factor: 4.195)[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802043/pdf/ijn-4-299.pdf]


13. Xu, Z., '''Mansour, H.M.''', and Hickey, A.J. ''Particle Interactions in Dry Powder Inhaler Unit Processes.'' [[Journal of Adhesion Science and Technology: Special Issue on Adhesion Aspects in Pharmaceutical Sciences]] (2011): 25 (4/5) 451-482. (Impact Factor: 1.175)[http://www.ingentaconnect.com/content/vsp/ast/2011/00000025/F0020004/art00009]


14. '''*Mansour, H.M.*''' ''It's Only Natural: Using Polymers in Drug Delivery.'' [[Pharmaceutical Technology]] (2009) 33 (1) January: 1-2. [http://pharmtech.findpharma.com/pharmtech/Article/Its-Only-Natural-Using-Polymers-in-Drug-Delivery/ArticleStandard/Article/detail/576273]
'''== 2010 =='''


15. '''*Mansour, H.M.*''', Rhee, Y.S., and Wu, X. ''Nanomedicine in Pulmonary Delivery.'' [[International Journal of Nanomedicine]] (2009) 4 December: 299-319.(Impact Factor: 4.976)[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802043/pdf/ijn-4-299.pdf]
10. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 1. Albuterol Sulfate and Disodium Cromoglycate.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 2: 3398-3414.(Impact Factor: 3.007)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22107/abstract]


16. '''*Mansour, H.M.*''', Sohn, M., Al-Ghananeem, A., and DeLuca P.P. ''Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects. Invited Paper.'' [[International Journal of Molecular Sciences: Special Issue-Material Sciences and Nanotechnology Section - Biodegradability of Materials in Biomedical Applications.]] (2010) 11: 3298-3322. (Impact Factor: 2.598)[http://www.mdpi.com/1422-0067/11/9/3298/pdf]
11. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 10: 3415-3429. (Impact Factor: 3.007)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22100/abstract]


17. Rhee, Y.S., Park, C.W., DeLuca, P.P., and '''*Mansour, H.M.*''' ''Sustained-Release Injectable Drug Delivery Systems. An Invited Paper.'' [[Pharmaceutical Technology: Special Issue-Drug Delivery]] (2010) November: 6-13. [http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Sustained-Release-Injectable-Drug-Delivery/ArticleStandard/Article/detail/694429?contextCategoryId=43497]
12. '''Mansour, H.M.''', Xu, Z., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Alternative Sugar Blends: 3. Trehalose Dihydrate and D-Mannitol Carriers.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March12; 3430-3441.(Impact Factor: 3.007)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22101/abstract]


18. Hayes, D. Jr.,  Zwischenberger, J.B., and '''Mansour, H.M.''' ''Aerosolized Tacrolimus: A Case Report in a Lung Transplant Recipient.'' [[Transplantation Proceedings]] (2010) 42 (9) November: 3876-3879. [http://www.transplantation-proceedings.org/article/S0041-1345%2810%2901240-6/abstract]
13. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Heterogenous Particle Deaggregation and Its Implications for Therapeutic Aerosol Performance.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 15: 3442-3461.(Impact Factor: 3.007)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22057/abstract]


19. Wu, X., Li, X., and  '''*Mansour, H.M.*''' ''Surface Analytical Techniques in Solid-State Particle Characterization: Implications for Predicting Performance in Dry Powder Inhalers. Invited Paper.'' [[KONA Powder and Particle Journal]] (2010) 28: 3-19.  [http://www.kona.or.jp/search/28_003.pdf]
14. '''Mansour, H.M.''', Sohn, M., Al-Ghananeem, A., and DeLuca P.P. ''Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects. Invited Paper.'' [[International Journal of Molecular Sciences: Special Issue-Material Sciences and Nanotechnology Section - Biodegradability of Materials in Biomedical Applications.]] (2010) 11: 3298-3322.  (Impact Factor: 2.339)[http://www.mdpi.com/1422-0067/11/9/3298/pdf]


20. Rhee, Y.S. and '''*Mansour, H.M.*''' ''Nanopharmaceuticals I: Nanocarrier Systems in Drug Delivery. Invited Paper.'' [[International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals.]] (2011) 8 (1/2): 84-114.[http://www.inderscience.com/search/index.php?action=record&rec_id=37172]
15. Rhee, Y.S., Park, C.W., DeLuca, P.P., and '''Mansour, H.M.''' ''Sustained-Release Injectable Drug Delivery Systems. An Invited Paper.'' [[Pharmaceutical Technology: Special Issue-Drug Delivery]] (2010) November: 6-13. [http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Sustained-Release-Injectable-Drug-Delivery/ArticleStandard/Article/detail/694429?contextCategoryId=43497]


21. Wu, X. and '''*Mansour, H.M.*''' ''Nanopharmaceuticals II: Application of Nanoparticles and Nanocarrier Systems in Pharmaceutics and Nanomedicine. Invited Paper.'' [[International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals.]] (2011) 8 (1/2): 115-145. (Impact Factor: 1.329)[http://www.inderscience.com/search/index.php?action=record&rec_id=37173&prevQuery=&ps=10&m=or]
16. Hayes, D. Jr.,  Zwischenberger, J.B., and '''Mansour, H.M.''' ''Aerosolized Tacrolimus: A Case Report in a Lung Transplant Recipient.'' [[Transplantation Proceedings]] (2010) 42 (9) November: 3876-3879.(Impact Factor: 1.061) [http://www.transplantation-proceedings.org/article/S0041-1345%2810%2901240-6/abstract]


22. Wu, X.,and '''*Mansour, H.M.*''' ''Pulmonary and Nasal Anti-Inflammatory and Anti-Allergy Inhalation Aerosol Delivery Systems. Invited Paper.'' [[Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry: Special Issue-Optimizing a Therapeutic with Anti-Inflammatory Agents: Novel Drug Delivery Systems.]] (2011)10 (3): 215-229. [http://www.benthamdirect.org/pages/b_viewarticle.php]
17. Wu, X., Li, X., and '''Mansour, H.M.''' ''Surface Analytical Techniques in Solid-State Particle Characterization: Implications for Predicting Performance in Dry Powder Inhalers. Invited Paper.'' [[KONA Powder and Particle Journal]] (2010) 28: 3-19/ (Impact Factor: 1.227) full text[https://www.jstage.jst.go.jp/article/kona/28/0/28_2010005/_pdf] [https://www.jstage.jst.go.jp/article/kona/28/0/28_2010005/_article]


23. Park, C.W., Hayes, D. Jr., and '''*Mansour, H.M.*''' ''Pulmonary Inhalation Aerosols for Targeted Antibiotics Drug Delivery. Invited Paper & Cover Page.'' [[European Pharmaceutical Review.]] (2011) 16 (1): 32-36.[http://www.europeanpharmaceuticalreview.com/tag/heidi-m-mansour/]


24. '''*Mansour, H.M.*''' ''Molecular Forces and Self Assembly in Colloid, Nano Sciences and Biology. Invited Paper.'' [[Journal of the American Chemical Society.]] (2011) 133 (13): 5162. (Impact Factor: 9.907) [http://pubs.acs.org/doi/pdf/10.1021/ja202080e]
'''== 2011 =='''


25. Hayes, D. Jr and '''Mansour, H.M.''' ''Improved Outcomes of Patients with End-Stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure.'' [[Lung.]] (2011) 189 (5): 409-415. (Impact Factor: 1.899)[http://www.springerlink.com/content/91526h6151744122/abstract/] [http://www.box.com/shared/ff53m3vfqy745tdr4un6]
18. Xu, Z., '''Mansour, H.M.''', and Hickey, A.J. ''Particle Interactions in Dry Powder Inhaler Unit Processes.'' [[Journal of Adhesion Science and Technology: Special Issue on Adhesion Aspects in Pharmaceutical Sciences]] (2011): 25 (4/5) 451-482. (Impact Factor: 1.175)[http://www.tandfonline.com/doi/abs/10.1163/016942410X525669#.U3KibigggWk]


26. Hayes, D. Jr., Ball, A.M., '''Mansour, H.M.''', Martin, C.A.,and Flynn, J.D. ''Fungal Infection in Heart-Lung Transplant Recipients Receiving Single-agent Prophylaxis With Itraconazole.'' [[Experimental and Clinical Transplantation]] (2011)9 (6): 399-404. [http://www.ectrx.org/forms/ectrxcontentshow.php?year=2011&volume=9&issue=6&supplement=0&makale_no=0&spage_number=399&content_type=PDF].
19. Rhee, Y.S. and '''Mansour, H.M.''' ''Nanopharmaceuticals I: Nanocarrier Systems in Drug Delivery. Invited Paper.'' [[International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals.]] (2011) 8 (1/2): 84-114.(Impact Factor: 1.144)[http://www.inderscience.com/search/index.php?action=record&rec_id=37172]


27. Rhee, Y.S., Sohn, M., Woo, B.H., Thanoo, B.C., DeLuca, P.P., and '''*Mansour, H.M.*''' ''Sustained-Release Delivery of Octreotide from Biodegradable Polymeric Microspheres.'' [[AAPS PharmSciTech: Special Theme Issue-Sterile Products: Advances and Challenges in Formulation, Manufacturing, Devices and Regulatory Aspects.]](2011)12 (4):1293-1301. (Impact Factor: 1.445)[http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12249-011-9693-z] [http://www.box.com/shared/6xo6dozy3aphdc111dsi]
20. Wu, X. and '''Mansour, H.M.''' ''Nanopharmaceuticals II: Application of Nanoparticles and Nanocarrier Systems in Pharmaceutics and Nanomedicine. Invited Paper.'' [[International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals.]] (2011) 8 (1/2): 115-145. (Impact Factor: 1.144)[http://www.inderscience.com/search/index.php?action=record&rec_id=37173&prevQuery=&ps=10&m=or]


28. Li, X. and '''*Mansour, H.M.*''' ''Physicochemical Characterization and Water Vapor Absorption of Organic Solution Advanced Spray Dried Trehalose Microparticles and Nanoparticles for Targeted Dry Powder Pulmonary Inhalation Delivery.'' [[AAPS PharmSciTech: Special Theme Issue: Advances in Pharmaceutical Excipients Research and Use: Novel Materials, Functionalities and Testing]] (2011)12(4):1420-1430. (Impact Factor: 1.445)[http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12249-011-9704-0] [http://www.box.com/shared/0omofu03jsg2s5vs8yym]
21. Wu, X.,and '''Mansour, H.M.''' ''Pulmonary and Nasal Anti-Inflammatory and Anti-Allergy Inhalation Aerosol Delivery Systems. Invited Paper.'' [[Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry: Special Issue-Optimizing a Therapeutic with Anti-Inflammatory Agents: Novel Drug Delivery Systems.]] (2011)10 (3): 215-229. [http://www.benthamdirect.org/pages/b_viewarticle.php]


29. Hayes, D. Jr., Winkler, M.A., Kirkby, S., Capasso, P., '''Mansour, H.M.''' and Attili, A.K. ''Preprocedural Planning with Prospectively Triggered Multi-Detector Row CT Angiography prior to Bronchial Artery Embolization in Cystic Fibrosis Patients with Massive Hemoptysis.'' [[Lung]] (2012)190 (2)April:221-225.(Impact Factor: 1.899)[http://www.springerlink.com/content/y761114p7m62451m/]
22. Park, C.W., Hayes, D. Jr., and '''Mansour, H.M.''' ''Pulmonary Inhalation Aerosols for Targeted Antibiotics Drug Delivery. Invited Paper & Cover Page.'' [[European Pharmaceutical Review.]] (2011) 16 (1): 32-36.[http://www.europeanpharmaceuticalreview.com/tag/heidi-m-mansour/]


30. Hayes, D. Jr. and '''Mansour, H.M.''' ''Vanishing Bronchus Intermedius Syndrome in a Pediatric Patient with Cystic Fibrosis After Lung Transplantation.'' [[Pediatric Transplantation: The Official Journal of the International Pediatric Transplant Association]] (2012): 1-5. [Impact Factor: 1.873](IN PRESS)[http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3046.2012.01682.x/abstract]
23. '''Mansour, H.M.''' ''Molecular Forces and Self Assembly in Colloid, Nano Sciences and Biology. Invited Paper.'' [[Journal of the American Chemical Society.]] (2011) 133 (13): 5162. (Impact Factor: 9.907) [http://pubs.acs.org/doi/pdf/10.1021/ja202080e]


31. Hayes, D. Jr., '''Mansour, H.M.''', Kirkby, S., and Phillips, A.B. ''Rapid Acute Onset of Bronchiolitis Obliterans Syndrome in a Lung Transplant Recipient After Respiratory Syncytial Virus Infection." [[Transplant Infectious Diseases]] (2012)14 (5): 548-550. [Impact Factor: 2.216] (IN PRESS)[http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3062.2012.00748.x/abstract;jsessionid=B6A3A133BAFC963F559C344343F14F9F.d03t04]
24. Hayes, D. Jr and '''Mansour, H.M.''' ''Improved Outcomes of Patients with End-Stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure.'' [[Lung.]] (2011) 189 (5): 409-415. (Impact Factor: 2.171)[http://www.springerlink.com/content/91526h6151744122/abstract/] [http://www.box.com/shared/ff53m3vfqy745tdr4un6]


32.Hayes, D Jr., Kirkby, S., McCoy, K.S., '''Mansour, H.M.''', Khosravi, M., Strawbridge, H., and Tobias, J.D. ''Reduction of Lipid-Laden Macrophage Index After Laproscopic Nissen Fundoplication in Cystic Fibrosis Patients After Lung Transplantation.'' [[Clinical Transplantation]] (2012) (Impact Factor: 1.677) [http://onlinelibrary.wiley.com/doi/10.1111/ctr.12020/abstract]
25. Hayes, D. Jr., Ball, A.M., '''Mansour, H.M.''', Martin, C.A.,and Flynn, J.D. ''Fungal Infection in Heart-Lung Transplant Recipients Receiving Single-agent Prophylaxis With Itraconazole.'' [[Experimental and Clinical Transplantation]] (2011)9 (6): 399-404. [http://www.ectrx.org/forms/ectrxcontentshow.php?year=2011&volume=9&issue=6&supplement=0&makale_no=0&spage_number=399&content_type=PDF].


33. Duan, J.H., '''Mansour, H.M.''', Zhang, Y.D., Deng, X.M., Zhao, J.F. ''Reversion of Multi-Drug Resistance by Co-Encapsulation of Doxorubicin and Curcumin in Chitosan/poly(butylcyanoacrylate) Nanoparticles.'' [[International Journal of Pharmaceutics]] (2012) 426 (1-2): 193-201. (Impact Factor: 3.350)[http://www.sciencedirect.com/science/article/pii/S0378517312000543?v=s5]
26. Rhee, Y.S., Sohn, M., Woo, B.H., Thanoo, B.C., DeLuca, P.P., and '''Mansour, H.M.''' ''Sustained-Release Delivery of Octreotide from Biodegradable Polymeric Microspheres.'' [[AAPS PharmSciTech: Special Theme Issue-Sterile Products: Advances and Challenges in Formulation, Manufacturing, Devices and Regulatory Aspects.]](2011)12 (4):1293-1301. (Impact Factor: 1.776)[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225556/pdf/12249_2011_Article_9693.pdf] [http://www.box.com/shared/6xo6dozy3aphdc111dsi]


34. Park, C.W., Rhee, Y.S., Vogt, F.G., Hayes, D Jr., Zwischenberger, J.B., DeLuca, P.P., and '''*Mansour, H.M.*''' ''Advances in Microscopy and Complementary Imaging Techniques to Assess the Fate of Drugs Ex-Vivo in Respiratory Drug Delivery. Invited Paper.'' [[Advanced Drug Delivery Reviews: Special Theme Issue-Computational and Visualization Approaches in Respiratory Delivery.]] (2012) 64 (4) March 30: 344-356. (Impact Factor: 11.502)[http://www.sciencedirect.com/science/article/pii/S0169409X11002298]
27. Li, X. and '''Mansour, H.M.''' ''Physicochemical Characterization and Water Vapor Absorption of Organic Solution Advanced Spray Dried Trehalose Microparticles and Nanoparticles for Targeted Dry Powder Pulmonary Inhalation Delivery.'' [[AAPS PharmSciTech: Special Theme Issue: Advances in Pharmaceutical Excipients Research and Use: Novel Materials, Functionalities and Testing]] (2011)12(4):1420-1430. (Impact Factor: 1.776)[http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12249-011-9704-0] [http://www.box.com/shared/0omofu03jsg2s5vs8yym]


35. Willis, M.L., Hayes, D Jr., and '''*Mansour, H.M.*''' ''Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery.'' [[Lung]] (2012) 190 (3): 251-262.(Impact Factor: 1.899)[http://www.springerlink.com/content/a833780030np6468/] [http://www.box.com/shared/2027z21x6myctpztvsk0]


36. Park, C.W., '''Mansour, H.M.''', Oh, T.O., Kim, J.Y., Ha, J.M., Lee, B.J., Chi, S.C., Rhee, Y.S., Park, E,S. "''Phase behavior of itraconazole-phenol mixtures and its pharmaceutical applications.''" [[International Journal of Pharmaceutics]] (2012)436 (1-2):652-658.(Impact Factor: 3.350) [http://www.sciencedirect.com/science/article/pii/S0378517312007752]
'''== 2012 =='''


37.'''*Mansour, H.M.*''' "''Aerosol Formulation Issues.''" [[Pediatric Pulmonology]] (2012) 47 (35):149-151. (Impact Factor: 2.533) [http://onlinelibrary.wiley.com/doi/10.1002/ppul.22681/abstract]
28. Hayes, D. Jr.,  Winkler, M.A., Kirkby, S., Capasso, P., '''Mansour, H.M.''' and Attili, A.K. ''Preprocedural Planning with Prospectively Triggered Multi-Detector Row CT Angiography prior to Bronchial Artery Embolization in Cystic Fibrosis Patients with Massive Hemoptysis.'' [[Lung]] (2012)190 (2)April:221-225.(Impact Factor: 2.171)[http://www.springerlink.com/content/y761114p7m62451m/]


38. Meenach, S.A. Vogt,F.G., Anderson, K.W., Hilt, J.Z., McGarry,R.C., and '''*Mansour, H.M.*'''. ''Design, Physicochemical Characterization, and Optimization of Organic Solution Advanced Spray-Dried Inhalable DPPC and DPPC:DPPE-PEG Microparticles and Nanoparticles for Targeted Respiratory Nanomedicine Delivery as Dry Powder Inhalation Aerosols.'' [[International Journal of Nanomedicine]] (2012) ''(in press)''(Impact Factor: 4.976)[http://www.dovepress.com/international-journal-of-nanomedicine-journal]
29. Hayes, D. Jr. and '''Mansour, H.M.''' ''Vanishing Bronchus Intermedius Syndrome in a Pediatric Patient with Cystic Fibrosis After Lung Transplantation.'' [[Pediatric Transplantation: The Official Journal of the International Pediatric Transplant Association]] (2012)16(8):333-337. [Impact Factor: 1.630][http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3046.2012.01682.x/abstract]


==Interview Articles ==
30. Hayes, D. Jr., '''Mansour, H.M.''', Kirkby, S., and Phillips, A.B. ''Rapid Acute Onset of Bronchiolitis Obliterans Syndrome in a Lung Transplant Recipient After Respiratory Syncytial Virus Infection." [[Transplant Infectious Diseases]] (2012)14 (5): 548-550. [Impact Factor: 2.25][http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3062.2012.00748.x/abstract;jsessionid=B6A3A133BAFC963F559C344343F14F9F.d03t04]
1. DeLuca, P.P. and  '''*Mansour, H.M.*''' ''Insight & Interview: Drug Delivery & Formulation-Controlled Release .'' [[World Pharmaceutical Frontiers]] (2011)2(September): 61-64.[http://www.worldpharmaceuticals.net/editorials/020/WPF020_ready-to-take-off.pdf]


2. '''*Mansour, H.M.*''' ''Insight & Interview: Meeting Manufacturing Challenges Tied to Extended-Release Injectables.'' [[Pharmaceutical Technology]] (2012) 36 (5): 40-47. [http://www.pharmtech.com/pharmtech/Feature+Articles/Meeting-Manufacturing-Challenges-Tied-to-Extended-/ArticleStandard/Article/detail/771896?contextCategoryId=43497]
31. Duan, J.H., '''Mansour, H.M.''', Zhang, Y.D., Deng, X.M., Zhao, J.F. ''Reversion of Multi-Drug Resistance by Co-Encapsulation of Doxorubicin and Curcumin in Chitosan/poly(butylcyanoacrylate) Nanoparticles.'' [[International Journal of Pharmaceutics]] (2012) 426 (1-2): 193-201. (Impact Factor: 3.785)[http://www.sciencedirect.com/science/article/pii/S0378517312000543?v=s5]


==Edited Book (co-Editor)==
32. Park, C.W., '''Mansour, H.M.''', Oh, T.O., Kim, J.Y., Ha, J.M., Lee, B.J., Chi, S.C., Rhee, Y.S., Park, E,S. "''Phase behavior of itraconazole-phenol mixtures and its pharmaceutical applications.''" [[International Journal of Pharmaceutics]] (2012) 436 (1-2):652-658.(Impact Factor: 3.785) [http://www.sciencedirect.com/science/article/pii/S0378517312007752]
1. [[Nanomedicine in Drug Delivery]], Kumar, A., '''Mansour, H.M.''', Friedman, A., and Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, London, United Kingdom. 450 pages. [http://www.crcpress.com/product/isbn/9781466506169]


==Book Chapters  *Corresponding Author*==
33. Park, C.W., Rhee, Y.S., Vogt, F.G., Hayes, D Jr., Zwischenberger, J.B., DeLuca, P.P., and '''Mansour, H.M.''' ''Advances in Microscopy and Complementary Imaging Techniques to Assess the Fate of Drugs Ex-Vivo in Respiratory Drug Delivery. Invited Paper.'' [[Advanced Drug Delivery Reviews: Special Theme Issue-Computational and Visualization Approaches in Respiratory Delivery.]] (2012) 64 (4) March 30: 344-356. (Impact Factor: 12.707)[http://www.sciencedirect.com/science/article/pii/S0169409X11002298]
1. Hickey, A.J. and '''Mansour, H.M.''' Book Volume 2, ''Book Chapter 43: Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols.'' [[Modified-Release Drug Delivery Technology, Drugs and the Pharmaceutical Sciences Series]], Rathbone, M. J., Hadgraft, J., Roberts, M.S., Lane, M.E, (Editors), Second Edition, Informa Healthcare, New York, (2008): pp. 573-602. [http://informahealthcare.com/doi/abs/10.3109/9781420045260.043?prevSearch=authorsfield%253A%2528Mansour%252C%2BHeidi%2BM.%2529&searchHistoryKey=]


2. Hickey, A.J. and '''Mansour, H.M.''' Book Volume 2, ''Chapter 5: Delivery of Drugs by the Pulmonary Route.'' [[Modern Pharmaceutics Volume 2: Applications and Advances, Drugs and the Pharmaceutical Sciences Series,]] Florence, A.T., Siepmann, J. (Editors), Fifth Edition, Informa Healthcare, New York, (2009): 191-219. [http://informahealthcare.com/doi/abs/10.3109/9781420065688.005?prevSearch=authorsfield%253A%2528Mansour%252C%2BHeidi%2BM.%2529&searchHistoryKey=]
34. Willis, M.L., Hayes, D Jr., and '''Mansour, H.M.''' ''Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery.'' [[Lung]] (2012) 190 (3): 251-262.(Impact Factor: 2.171)[http://www.springerlink.com/content/a833780030np6468/] [http://www.box.com/shared/2027z21x6myctpztvsk0]


3. '''*Mansour, H.M.*''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]
35.'''Mansour, H.M.''' "''Aerosol Formulation Issues.''" [[Pediatric Pulmonology]] (2012) 47 (35):149-151. (Impact Factor: 2.297) [http://onlinelibrary.wiley.com/doi/10.1002/ppul.22681/abstract]


4. '''*Mansour, H.M.*''', Park, C.W., and Bawa, R. ''Book Chapter 6: Design and Development of Approved Nanopharmaceutical Products.'' [[Clinical Nanomedicine: from Bench to Bedside. Series in Nanomedicine]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing/CRC Press, Boca Raton, FL, (2012): pp. 1-27.


5.'''*Mansour, H.M.*''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor Francis, Inc., London, United Kingdom (2012). [http://www.crcpress.com/product/isbn/9781466506169]
'''== 2013 =='''


6. '''*Mansour, H.M.*''' and Park, C.W. ''Book Chapter: Therapeutics and Targeted Delivery of Nanomedicines and Nanopharmaceutical Products.'' [[The Clinical Nanomedicine Handbook.]] CRC Press, Inc., London, United Kingdom (2012). [http://www.crcpress.com/product/isbn/9781439834787]
36. Meenach, S.A. Vogt,F.G., Anderson, K.W., Hilt, J.Z., McGarry,R.C., and  '''Mansour, H.M.'''. ''Design, Physicochemical Characterization, and Optimization of Organic Solution Advanced Spray-Dried Inhalable Dipalmitoylphosphatidylcholine (DPPC) and Dipalmitoylphosphatidylethanolamine Poly(Ethylene Glycol) (DPPE-PEG) Microparticles and Nanoparticles for Targeted Respiratory Nanomedicine Delivery as Dry Powder Inhalation Aerosols.'' [[International Journal of Nanomedicine]] (2013) 8:275-293.(Impact Factor: 4.195)[http://www.dovepress.com/getfile.php?fileID=14947]


7.'''*Mansour, H.M.*''', Park, C.W., Rhee, Y.S., and DeLuca, P.P. ''Book Chapter: Novel Drug Delivery Systems.'' [[Drug Delivery.]] Mitra, A.K. (Editor), First Edition,  Jones & Bartlett, Burlington, MA. (2012).
37. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.''' ''Characterization and Aerosol Dispersion Performance of Advanced Spray-Dried Chemotherapeutic PEGylated Phospholipid Particles for Dry Powder Inhalation Delivery in Lung Cancer.'' [[European Journal of Pharmaceutical Sciences]] (2013) 49 (4): 699-711.(Impact Factor: 3.005)[http://www.sciencedirect.com/science/article/pii/S0928098713001917]


== Professional Memberships==
38. Wu,X., Hayes, D Jr., Zwischenberger, J.B., Kuhn, R.J., and '''Mansour, H.M.''' ''Design and Physicochemical Characterization of Advanced Spray-Dried Tacrolimus  Multifunctional Particles for Inhalation.'' [[Drug Design, Development, and Therapy]]  (2013) 7:59-72. (Impact Factor: 3.026) [http://www.dovepress.com/getfile.php?fileID=15100]
* Academy of Pharmaceutical Sciences of Great Britain
* American Association for Aerosol Research
* American Association of Colleges of Pharmacy
* American Association of Pharmaceutical Scientists
* American Chemical Society
* American Pharmacists Association
* American Society of Nanomedicine
* Controlled Release Society
* European Federation for Pharmaceutical Sciences
* European Cystic Fibrosis Society
* Golden Key
* International Association of Colloid and Interface Scientists
* International Liposome Society
* International Microencapsulation Society
* International Pharmaceutical Federation
* International Society for Aerosols in Medicine
* Phi Eta Sigma
* Phi Kappa Phi
* Rho Chi
* United States Pharmacopeia (USP)-UK COP Delegate


==Research Lab Group Members==
39. Wu,X., Zhang, W., Hayes, D Jr., and '''Mansour, H.M.''' ''Physicochemical Characterization and Aerosol Dispersion Performance of Organic Solution Advanced Spray-Dried Cyclosporine A Multifunctional Particles for Dry Powder Inhalation Aerosol Delivery.'' [[International Journal of Nanomedicine]] (2013) 8 :1269-1283.(Impact Factor: 4.195)[http://www.dovepress.com/getfile.php?fileID=15566]
1. Dr. Yun-Seok Rhee, Ph.D., Postdoctoral Research Scholar


2. Dr. Xiao Wu, Ph.D., Postdoctoral Research Scholar
40. Park, C.W., Li X., Vogt, F.G., Hayes, D. Jr., Zwischenberger, J.B., Park, E.S. and '''Mansour, H.M.''' ''Advanced Spray Dried Design, Physicochemical Characterization and Aerosol Dispersion Performance of Vancomycin and Clarithromycin Multifunctional Controlled Release Particles for Targeted Respiratory Delivery as Dry Powder Inhalation Aerosols..'' [[International Journal of Pharmaceutics]] (2013) 455 (1–2): 374–392.(Impact Factor: 3.785)[http://www.sciencedirect.com/science/article/pii/S0378517313005565]


3. Dr. Chun-Woong Park, Ph.D., Postdoctoral Research Scholar
41. Zheng Z, Zhang W, Sun W, Li X, Duan J, Cui J, Feng Z, and '''Mansour, H.M.''' ''Influence of the Carboxymethyl Chitosan Anti-Adhesion Solution on the TGF-β1 in a Postoperative Peritoneal Adhesion Rat.'' [[Journal of Materials Science: Materials in Medicine]] (2013) 24 (11): 2549-2559. (Impact Factor: 2.379) [http://link.springer.com/article/10.1007/s10856-013-4981-7]


4. Dr. Jinghua Duan, Ph.D., Postdoctoral Research Scholar
42. Duan J.H., Vogt, F.G., Li X., Hayes, D. Jr., and '''Mansour, H.M.''' ''Design, Physicochemical Characterization and Aerosolization of Organic Solution Advanced Spray Dried and Co-Spray Dried Moxifloxacin and Ofloxacin Dipalmitoylphosphatidylcholine (DPPC) Microparticulate/Nanoparticulate Powders for Pulmonary Inhalation Aerosol Delivery.'' [[International Journal of Nanomedicine]] (2013) 8: 3489-3505.  [http://www.dovepress.com/getfile.php?fileID=17495](Impact Factor: 4.195)


5. Dr. Samantha Meenach, NIH NCI CNTC Postdoctoral Fellow
43. Hayes, D. Jr., Galantowicz, M., Yates, A.R., Preston, T.J., '''Mansour, H.M.''', and McConnell, P.I. ''Venovenous ECMO as a Bridge to Lung Transplant and Protective Strategy for Subsequent Primary Graft Dysfunction.'' [[Journal of Artificial Organs]] (2013) 16 (3): 382-385. (Impact Factor: 1.60)[http://link.springer.com/article/10.1007%2Fs10047-013-0699-z]


6. Dr. Wei Fen Zhang, Visiting Professor
44. Hayes, D. Jr., Baker, P.B., '''Mansour, H.M.''', Peeples, M.E., and Nicol, K.K. ''Interstitial Lung Disease in a Child with Antisynthetase Syndrome.'' [[Lung]] (2013) 191 (4): 441-443. (Impact Factor: 2.171)[http://link.springer.com/article/10.1007%2Fs00408-013-9468-2]


7. Dr. Scott Silva, Ph.D., M.D.,Postdoctoral Physician-Scientist Research Fellow
45.Hayes, D. Jr., Daniels, C.J., '''Mansour, H.M.''', Kopp, B.T., Yates, A.R., McCoy, K.S., Patel, A.V., and Kirby, S. ''Right Heart Catherization Measuring Central Hemodynamics in Cystic Fibrosis During Exercise.'' [[Respiratory Medicine]] (2013): 107 (9): 1365–1369. [Impact Factor: 2.917][http://www.sciencedirect.com/science/article/pii/S0954611113002096]


8. Dr. Sung Gu Han, Ph.D., Postdoctoral Research Associate
46. Hayes, D. Jr., Daniels, C.J., '''Mansour, H.M.''', Kopp, B.T., Yates, A.R., Preston, T., and Kirby, S. ''Identification of the Nodose Ganglia and TRPV1 in Swine.'' [[Lung]] (2013): 191(5):445-447(Impact Factor: 2.171)[http://link.springer.com/content/pdf/10.1007%2Fs00408-013-9496-y.pdf]


9. MinJi Sohn, M.S., Visiting Graduate Student Research Scholar
47.Hayes, D Jr., Kirkby, S., McCoy, K.S., '''Mansour, H.M.''', Khosravi, M., Strawbridge, H., and Tobias, J.D.  ''Reduction of Lipid-Laden Macrophage Index After Laproscopic Nissen Fundoplication in Cystic Fibrosis Patients After Lung Transplantation.'' [[Clinical Transplantation]] (2013) 27 (1): 121-125.(Impact Factor: 1.486) [http://onlinelibrary.wiley.com/doi/10.1111/ctr.12020/abstract]


10. Xiaojian Li, M.S., Doctoral Candidate (Dissertator), Center of Membrane Sciences Fellow, S. Elizabeth Helton Memorial Scholar in Pulmonary Research


11. Lauren Willis, Pharm.D. Student Researcher
'''== 2014 =='''


12. Amber Jerke, NSF-REU Research Fellow
48. Hayes, D. Jr., Yates, A.R., Duffy, V., Tobias, J., '''Mansour, H.M.''', Olshove, V., and Preston, T.J. ''Rapid placement of bicaval dual-lumen catheter in a swine model of venovenous ECMO.'' [[Journal of Investigative Surgery]] (2014): 27(1):27-31. [Impact Factor: 1.316] [http://informahealthcare.com/doi/abs/10.3109/08941939.2013.826311]


13. Charles Ritchie, HPLC Research Technician
49. Hayes, D. Jr., Adler, B., Turner, T.L., and '''Mansour, H.M.'''. ''Alternative Tacrolimus and Sirolimus Regimen Associated with Rapid Resolution of Posterior Reversible Encephalopathy Syndrome After Lung Transplantation.''  [[Pediatric Neurology]] (2014) 50: 272-275.(Impact Factor: 1.504)[http://www.sciencedirect.com/science/article/pii/S0887899413006693]


14.Wei Qui, Animal Research Technician
50. Li X., Vogt, F.G., Hayes, D. Jr., and '''Mansour, H.M.''' ''Physicochemical Characterization and Aerosol Dispersion Performance of Organic Solution Advanced Spray Dried Microparticulate/Nanoparticulate Antibiotic Dry Powders of Tobramycin and Azithromycin for Pulmonary Inhalation Aerosol Delivery.'' [[European Journal of Pharmaceutical Sciences]] (2014) 15: 191-205. (Impact Factor: 3.005) [http://elsarticle.com/1ej23qD]


==Co-Advisor Lab Group Members==
51.Li X., Vogt, F.G., Hayes, D. Jr., and '''Mansour, H.M.''' ''Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Spray-Dried Microparticulate/Nanoparticulate Mannitol Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers.'' [[Journal of Aerosol Medicine & Pulmonary Drug Delivery]] (2014): 27 (2):81-93. (Impact Factor: 2.395)[http://online.liebertpub.com/doi/pdfplus/10.1089/jamp.2013.1078]


1. Nathanael Stocke, NSF-IGERT Fellow, College of Engineering
52. Li X., Vogt, F.G., Hayes, D. Jr., and '''Mansour, H.M.''' ''Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Co-Spray Dried Antibiotics with Mannitol as Respirable Microparticles/Nanoparticles for Targeted Pulmonary Delivery as Dry Powder Inhalers.'' [[Journal of Pharmaceutical Sciences: George Zografi Dedicated Issue]] (2014)103(9): 2937-2949. [Impact Factor: 3.007][http://onlinelibrary.wiley.com/doi/10.1002/jps.23955/abstract]


2. Alexander McKinlay, NSF-REU Fellow, Department of Biomedical Engineering
53.  Muralidharan, P., Mallory, E., Malapit, M., Hayes, D. Jr., and '''Mansour, H.M.''' ''Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers.'' [[Pharmaceutics: Special Issue: Liposomal Technologies (Guest Editor: Prof. Timothy D. Heath, UW-Madison) ]] (2014) 6 (2): 333-353. [http://www.mdpi.com/journal/pharmaceutics/special_issues/liposome_technologies#planned] [http://www.mdpi.com/1999-4923/6/2/333/pdf]


== Meeting Abstracts selected from 2006-Present (over 30 abstracts prior to 2006)*Presenting Author* ==
54. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.''' ''High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies.'' [[AAPS PharmSciTech: Theme Issue on Advances in Formulation and Device Technologies in Pulmonary Drug Delivery]]  (2014)15(6) December:1574-1587. [Impact Factor: 1.776] [http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12249-014-0182-z]  [http://link.springer.com/article/10.1208/s12249-014-0182-z]


'''''National and International Meeting Abstracts'''''
55. Hayes, D. Jr., Tobias, J.D., '''Mansour, H.M.''', Kirkby, S., McCoy, K.S., Daniels, C.J., and Whitson, B.A. ''Pulmonary Hypertension in Cystic Fibrosis with Advanced Lung Disease.'' [[American Journal of Respiratory and Critical Care Medicine]] (2014) 190 (8):898-905. [Impact Factor: 11.986] [http://www.atsjournals.org/doi/abs/10.1164/rccm.201407-1382OC?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed] <BR>
“F1000Prime Recommended by F1000Respiratory Disorders Faculty” [http://f1000.com/prime/718875747?bd=1&ui=22079]


1.'''*Mansour, H.M.*''', Damodaran, S., and Zografi, G. ''Surface Structural Characterization and Effects of a Surface-Active, Hydrophobic Heteropolypeptide, KL4, on Phospholipid Bilayer Spreading and Monolayer Phase Behavior at the Air-Water Interface:  Implications for Pulmonary Surfactant Delivery.'' [[The 10th Annual Liposome Research Days & The 1st Univ. of North Carolina Drug Conference]], Chapel Hill, NC, 2006.


2.'''*Mansour, H.M.*''', Kujanpää, J., Tuomenoja, H., Papadopoulos, D., Mulder, T., Langridge, J., and Hickey, A.J.  ''Characterization of the Effects of Various Sugar Carriers and Inhalation Devices on the Surface Electrostatics of Aerosolized Dry Powder Inhalation Particles containing Albuterol Sulfate.''  [[The AAPS Journal]] (2006) 8 (S2) M1239.
'''== 2015 =='''


3.'''*Mansour, H.M.*''', Kujanpää, J., Tuomenoja, H., and Hickey, A.J.  ''Electrostatic Charge Behavior of Aerosolized Pharmaceutical Particles for Various Drug/Sugar Carrier Dry Powder Inhalation Particulate Systems.'' [[The AAPS Journal]] (2006) 8 (S2) M1245.  
56. Stocke, N., Meenach, S.A.,Arnold, S.M., '''Mansour, H.M.*''',and Hilt, J.Z.  ''Formulation and Characterization of Inhalable Magnetic Nanocomposite Microparticles (MnMs) for Targeted Pulmonary Delivery via Spray Drying.'' [[International Journal of Pharmaceutics]] (2015) 479 (2): 320–328. '''*'''Corresponding Authors [Impact Factor: 3.785] [http://www.sciencedirect.com/science/article/pii/S0378517314009478]


4.'''*Mansour, H.M.*''', Xu, Z., and Hickey, A.J.  ''Characterization of Dry Powder Aerosols of Albuterol Sulfate and Cromolyn Sodium with Various Sugar Carriers Delivered by Standardized Entrainment Tubes.'' [[The AAPS Journal]] (2007) 9 (S2) W5234.  
57. Hayes, D. Jr., McCoy, K.S., Whitson, B.A., '''Mansour, H.M.''' , and Tobias, J.D.  ''High-Risk Age Window for Mortality in Children with Cystic Fibrosis after Lung Transplantation.'' [[Pediatric Transplantation]] (2015)19(2):206-210.(Impact Factor: 1.63)[http://onlinelibrary.wiley.com/doi/10.1111/petr.12401/abstract]


5.Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J.  ''Characterization of Dry Powder Aerosols of Albuterol Sulfate/Lactose Monohydrate and Cromolyn Sodium/Lactose Monohydrate Delivered by Standardized Entrainment Tubes.'' [[The AAPS Journal]] (2007) 9 (S2) W5235.  
58. Hayes, D. Jr., Black, S.M., Tobias, J.D., '''Mansour, H.M.''', and Whitson, B.A. ''Influence of pulmonary hypertension on survival in advanced lung disease.'' [[Lung]] (2015)193(2):213-21. [Impact Factor: 2.171][http://link.springer.com/article/10.1007/s00408-015-9696-8]


6.Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Performance Evaluation of Dry Powder Aerosol Formulation Using Modified Surface Adsorption Expression.'' [[The AAPS Journal]] (2009) (S2) R6197.
59. Hayes, D. Jr., Black, S.M., Tobias, J.D., '''Mansour, H.M.''', and Whitson, B.A. ''Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation.'' [[COPD: Journal Of Chronic Obstructive Pulmonary Disease]] (IN PRESS) [Impact Factor: 2.620]


7.Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Heterogenous Particle Deaggregation and Its Implication for Therapeutic Aerosol Performance.'' [[The AAPS Journal]] (2009) (S2) R6198.
60. Muralidharan, P., Hayes, D. Jr., and '''Mansour, H.M.''' ''Dry Powder Inhalers in COPD, Lung Inflammation, and Pulmonary Infections.'' [[Expert Opinion on Drug Delivery: Theme Issue on Drug Delivery to the Lungs]] (2015) 1-16. (Impact Factor: 4.116)[http://informahealthcare.com/doi/abs/10.1517/17425247.2015.977783]


8.'''Mansour, H.M.''', Sohn, M., Rhee, Y.S., Woo, B., and DeLuca P.P. ''Sustained Release Delivery of Octreotide Acetate from Biodegradeable Polymeric Microspheres.'' [[The AAPS Journal]] (2009) (S2) W5036.
61. Muralidharan, P., Malapit, M., Mallory, E., Hayes, D. Jr., and '''Mansour, H.M.''' ''Inhalable Nanoparticulate Powders for Respiratory Delivery. Invited Paper.'' [[Nanomedicine: Nanotechnology, Biology, and Medicine]] (2015)IN PRESS. [Impact Factor: 5.978][http://www.nanomedjournal.com/article/S1549-9634%2815%2900031-3/abstract][http://www.sciencedirect.com/science/article/pii/S1549963415000313]


9.Li, X. and '''Mansour, H.M.''' ''Physicochemical Characterization and Water Vapor Sorption of Advanced Spray Dried Trehalose Microparticles and Nanoparticles in the Solid-State for Targeted Pulmonary Delivery as Dry Powders.'' [[Pharmaceutics Graduate Student Research Meeting (PGSRM)]]. The Ohio State University College of Pharmacy, Columbus, OH. (June 2010).
==Edited Book (co-Editor)==
1. [[Nanomedicine in Drug Delivery]], Kumar, A., '''Mansour, H.M.''', Friedman, A., and Blough, E. (Editors), CRC Press/Taylor & Francis, London, United Kingdom. (2013) 469 pages. ISBN: 9781466506169 [http://www.crcpress.com/product/isbn/9781466506169][http://books.google.com/books?hl=en&lr=&id=QWhSMfsn6tYC&oi=fnd&pg=PP1&dq=info:Lf0jl2sCR2EJ:scholar.google.com&ots=wxUAiFY--3&sig=tX2bBhGxBV0twoAczpmjuezUt2U#v=onepage&q&f=false][http://www.taylorandfrancis.com/books/details/9781466506169/]


10.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Advanced Spray Dried Particles for Targeted Pulmonary Delivery in Lung Cancer.'' [[Pharmaceutics Graduate Student Research Meeting (PGSRM)]]. The Ohio State University College of Pharmacy, Columbus, OH. (June 2010).
==Book Chapters==
1. Hickey, A.J. and '''Mansour, H.M.''' Book Volume 2, ''Book Chapter 43: Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols.'' [[Modified-Release Drug Delivery Technology, Drugs and the Pharmaceutical Sciences Series]].728 pages. Rathbone, M. J., Hadgraft, J., Roberts, M.S., Lane, M.E, (Editors), Second Edition, Informa Healthcare, New York, (2008): pp. 573-602. ISBN: 9781420053555 [http://informahealthcare.com/doi/abs/10.3109/9781420045260.043?prevSearch=authorsfield%253A%2528Mansour%252C%2BHeidi%2BM.%2529&searchHistoryKey=]


11.Wu, X. and '''Mansour, H.M.''' ''Advanced Spray Dried Tacrolimus Particles for Lung Transplant Immunosuppression By Targeted Dry Powder Pulmonary Inhalation Delivery.'' [[Pharmaceutics Graduate Student Research Meeting (PGSRM)]]. The Ohio State University College of Pharmacy, Columbus, OH. (June 2010).
2. Hickey, A.J. and '''Mansour, H.M.''' Book Volume 2, ''Book Chapter 5: Delivery of Drugs by the Pulmonary Route.'' [[Modern Pharmaceutics Volume 2: Applications and Advances, Drugs and the Pharmaceutical Sciences Series,]].500 pages. Florence, A.T., Siepmann, J. (Editors), Fifth Edition, Informa Healthcare, New York, (2009): 191-219. ISBN: 9781420065664 [http://informahealthcare.com/doi/abs/10.3109/9781420065688.005?prevSearch=authorsfield%253A%2528Mansour%252C%2BHeidi%2BM.%2529&searchHistoryKey=]


12.Li, X. and '''*Mansour, H.M.*''' ''Quality-By-Design for Excipient Functionality: Advanced Spray-Dried Trehalose Microparticles and Nanoparticles for Targeted Pulmonary Inhalation Delivery.'' [[International Pharmaceutical Excipient Council (IPEC) Excipient Fest 2011]], Baltimore, MD. (Mansour, H. M. Presenting Author).
3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 306 pages. Moghis, A. (Editor), American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2012): pp.221-268.ISBN: 9780981893679 [https://aocs.personifycloud.com/PersonifyEbusiness/Store/ProductDetails.aspx?productId=112814]


13.Park, C.W, Hayes, D. Jr., and '''Mansour, H.M.''' ''Advanced Spray-dried Vancomycin hydrochloride and Clarithromycin Particles for Targeted Pulmonary Inhalation Delivery as Dry Powders.'' [[Controlled Release Society Annual Meeting & Exhibition 2011]] National Harbor, MD.
4. '''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] 469 pages. Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), CRC Press/Taylor & Francis, Inc., London, United Kingdom.  (2013): pp.43-74. ISBN: 9781466506169 [http://www.crcpress.com/product/isbn/9781466506169] [http://books.google.com/books?hl=en&lr=&id=QWhSMfsn6tYC&oi=fnd&pg=PP1&dq=info:Lf0jl2sCR2EJ:scholar.google.com&ots=wxUAiFY--3&sig=tX2bBhGxBV0twoAczpmjuezUt2U#v=onepage&q&f=false][http://www.taylorandfrancis.com/books/details/9781466506169/]


14.Li, X., Hayes, D. Jr, and '''Mansour, H.M.''' ''Advanced Spray Dried Microparticles/Nanoparticles of Antibiotics and a Mucolytic in the Solid-state for Cystic Fibrosis Treatment by Targeted Pulmonary Delivery.'' [[Controlled Release Society Annual Meeting & Exhibition 2011]] National Harbor, MD.
5. '''Mansour, H.M.''' and Park, C.W. ''Book Chapter 7: Therapeutic Applications and Targeted Delivery of Nanomedicines and Nanopharmaceutical Products.'' [[The Clinical Nanomedicine Handbook.]] 365 pages. Brenner, S.A. (Editor), CRC Press/Taylor & Francis, Inc., London, United Kingdom.  (2013): pp.321-338. ISBN: 9781439834787 [http://www.crcpress.com/product/isbn/9781439834787]


15.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Advanced Spray Dried Particles for Targeted Pulmonary Delivery in Lung Cancer.'' [[Controlled Release Society Annual Meeting & Exhibition 2011]] National Harbor, MD.
6. '''Mansour, H.M.''', Xu, Z., Meenach, S.A., Park, C.W., Rhee, Y.S., and DeLuca, P.P. ''Book Chapter 5: Novel Drug Delivery Systems.'' [[Drug Delivery.]] 550 pages. Mitra, A.K. (Editor), Jones & Bartlett, Burlington, MA. (2015): pp.71-107. ISBN-13: 9781284025682 [http://www.jblearning.com/catalog/9781284025682/]


16.'''*Mansour, H.M.*''' ''Rational Design, Development, and Optimization of Nanopharmaceuticals for Targeted Drug Delivery in Nanomedicine-An Interfacial and Colloidal Science Approach.'' [[242th American Chemical Society (ACS) 2011 Annual Meeting-ACS Colloid & Surfaces Symposium on Nanomedicine]].ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY Volume: 242  Meeting Abstract: 281-COLL (August 2011) (Mansour, H.M. Presenting Author/Invited Speaker/Session Presider).
7. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 9: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside.]] 1000+ pages. Bawa,R., Audette, G., and Rubinstein, I. (Editors), Pan Stanford Publishing, Singapore.  (2015): pp.1-40. ISBN: 9789814316170 [http://www.panstanford.com/books/9789814316170.html]
[http://www.crcpress.com/product/isbn/9789814316170]


17.'''*Mansour, H.M.*''' ''Phospholipid  Nanopharmaceuticals in Advanced Drug Delivery.'' [[2011 American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Symposium on “Phospholipids in Pharma and Cosmetics Applications"]], Cincinnati, OH. (Symposium Speaker).
8. '''Mansour, H.M.''', Muralidharan, P., and Hayes, D. Jr. ''Book Chapter 8b: Inhaled Nanoparticulate Systems: Composition, Manufacture, and Aerosol Delivery.'' [[The ISAM Textbook of Aerosol Medicine.]] Dhand, R. (Editor-in-Chief), Rothen-Rutishauser, B., and Hickey A.J. (Associate Editors), International Society of Aerosols in Medicine (ISAM)/Mary Ann Libert Publishing, Inc. Rochelle, NY. (2015).


18.Stocke, N., '''Mansour, H.M.''', and Hilt, J.Z. ''Enhanced Transport of PEG-Based Magnetic Nanocomposites In Artificial Mucus Barriers.'' [[2011 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition, "Nanoscale Science and Engineering Forum"]].
9. '''Mansour, H.M.''', Myrdal, P.B., Younis, U., Muralidharan, P., and Hayes, D. Jr. ''Book Chapter 12: Pulmonary Drug Delivery.'' [[Drug Delivery & Targeting.]] Hillery, A.M., Swarbrick, J., and Park, K., (Editors), Second Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2015)


19. Li, X., Hayes, D. Jr, and '''Mansour, H.M.''' ''Advanced Spray-Dried Microparticulate/Nanoparticulate Powders for Cystic Fibrosis Treatment by Targeted Pulmonary Delivery.'' [[2011 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting & Exhibition]].
== Professional Memberships==
 
1.Academy of Pharmaceutical Sciences of Great Britain (APSGB)
20. '''*Mansour, H.M.*''', Park, C.W, Vogt, F.G., and Hayes, D. Jr. ''Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Aerosol Delivery''. [[4th Annual Nanotechnology & Nanomedicine Symposium]].
 
21. '''*Mansour, H.M.*''', Li, X, and Hayes, D. Jr. ''TARGETED LUNG DELIVERY BY INHALABLE MULTIFUNCTIONAL MICROPARTICULATE/NANOPARTICULATE AEROSOLS FOR CYSTIC FIBROSIS COMBINATION DRUG/MUCOLYTIC TREATMENT.'' [[Pediatric Pulmonology Journal]] (2011) Supplement Issue 34: 346. (presentation at the 2011 North American Cystic Fibrosis Conference (NACFC) Annual Meeting & Exhibition), Anaheim, CA (November 2011).
 
22. Meenach, S.A., McGarry, R.C., Hilt, J.Z., Anderson, K.W., and '''Mansour, H.M.''' ''Advanced Spray Dried Microparticulate/Nanoparticulate Inhalable Polymeric Lipospheres Containing Paclitaxel for Targeted Pulmonary Nanomedicine in Lung Cancer Treatment.'' [[39th Annual Controlled Release Society Meeting & Exhibition 2012]], Quebec, Canada (July 2012).
 
23.Hayes, D. Jr., Yates, A.R., Duffy, V.L., Chicoine, L.G., Nicol, K.K., '''Mansour, H.M.''', McConnell, P.I., Preston, T.J.  ''Placement of a Bicaval Dual-lumen Catheter in Piglets Using Anatomical Landmarks and Confirmation with Transthoracic Echocardiography Doppler Imaging in a Model of Single-Venous Venovenous Extracorporeal Membrane Oxygenation.'' [[CHEST 2012 Annual Meeting]],Atlanta, GA. [[CHEST]](2012) 142 (4):770A.[http://journal.publications.chestnet.org/article.aspx?articleid=1376292]
 
24. Hayes, D. Jr., Kopp, B.T., '''Mansour, H.M.''', Kirkby, S., Yates, A.R., McCoy, K.S.,  Daniels, C.J.  ''Exercise-induced Pulmonary Arterial Hypertension in Pediatric and Young Adult Patients with Cystic Fibrosis.'' [[CHEST 2012 Annual Meeting]], Atlanta, GA. [[CHEST]](2012) 142 (4):773A. [http://journal.publications.chestnet.org/article.aspx?articleid=1376288]
 
25.Meenach, S.A., McGarry, R.C., Hilt, J.Z., Anderson, K.W., and '''Mansour, H.M.''' ''Characterization and Optimization of Inhalable PEGylated Phospholipid Microparticles and Nanoparticles Containing Paclitaxel for Targeted Pulmonary Nanomedicine in Lung Cancer as Dry Powder Inhalers.'' [[2012 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition]],  Pittsburgh, PA (October 2012).
 
26.Meenach, S.A., Tsoras, A.N., McGarry, R.C., '''Mansour, H.M.''' ,  Hilt, J.Z., and Anderson, K.W. ''Development of Three-Dimensional Lung Multicellular Spheroids in Air and Liquid Interface Culture for the Evaluation of Anti-Cancer Therapeutics.''  [[2012 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition]],  Pittsburgh, PA (October 2012)
 
27.Stocke, N., Meenach, S.A., Anderson, K.W., '''Mansour, H.M.''' , and  Hilt, J.Z. ''Development of Inhalable Iron Oxide Nanocomposites for Application in Lung Cancer Therapy.''  [[2012 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition]],  Pittsburgh, PA (October 2012)


28. Stocke, N., Zhang, X., '''Mansour, H.M.''',  DeRouchey, J., and  Hilt, J.Z., ''Probe Diffusion in Poly(ethylene glycol)-based Hydrogels Studied by Fluorescence Correlation Spectroscopy.'' [[2012 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition]],  Pittsburgh, PA (October 2012)
2.American Thoracic Society (ATS)


29. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.''' ''Characterization and Optimization of Inhalable PEGylated Phospholipid Microparticles and Nanoparticles Containing Paclitaxel for Targeted Pulmonary Nanomedicine in Lung Cancer.'' [[2012 Society for Biomaterials Conference-Biomaterials Day]],  Lexington, KY (October 2012).'''1st Place-Best Oral Presentation Award'''
3.American Pharmacists Association (APhA)[http://archive.aphafoundation.org/AM/customsource/donations/paveimages/Paver_Photo.asp?paverid=O33]


30. Li, X., Vogt, F.G., Hayes, D. Jr, and '''Mansour, H.M.''' ''Design and Aerosol Dispersion Performance of Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Mucolytic Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers.'' [[2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting & Exhibition]],  Chicago, IL. (October 2012)
4.American Chemical Society (ACS)


31. Li, X., Vogt, F.G., Hayes, D. Jr, and '''Mansour, H.M.'''  ''Design and Aerosol Dispersion Performance of Organic Solution Advanced Co-Spray-Dried Multifunctional Microparticulate/Nanoparticulate Aerosol Formulations for Targeted Pulmonary Delivery as Dry Powder Inhalers.'' [[2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting & Exhibition]],  Chicago, IL. (October 2012)
5.American Association of Pharmaceutical Scientists (AAPS)


32. Li, X., Vogt, F.G., Hayes, D. Jr, and '''Mansour, H.M.''' ''Design and Aerosol Dispersion Performance of Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Mucolytic Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers in Cystic Fibrosis.'' [[Pediatric Pulmonology Journal]] (2012) 47: 360-361.(presentation at the 2012 North American Cystic Fibrosis Conference (NACFC) Annual Meeting, Orlando, FL.) (October 2012)
6.American Association of the Colleges of Pharmacy (AACP)


'''''UK Meeting Abstracts'''''
7.American Society for Nanomedicine (ASNM)


1.Jerke, A., Dziubla, T.D., and '''Mansour, H.M.''' ''Physical and Chemical Characterization of Various Pulmonary Drugs and Sugars for Targeted Pulmonary Delivery.'' [[NSF-REU Summer Research Symposium]], University of Kentucky College of Engineering, Lexington, KY (July 2009)
8.Controlled Release Society (CRS)


2.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Advanced Spray Dried Particles for Targeted Pulmonary Delivery in Lung Cancer.'' [[NSF-IGERT Spring Research Symposium]], University of Kentucky College of Engineering, Lexington, KY (May 2010)
9.European Federation for Pharmaceutical Sciences (EUFPS)


3.Williamson, J. and '''Mansour, H.M.''' ''Advanced Co-Spray Dried Disodium Cromoglycate and Fluticasone Propionate Microparticles and Nanoparticles for Combination Drug Pulmonary Inhalation Delivery.'' [[UK COP SURP Research Symposium]], Lexington, KY (July 2010).
10.International Pharmaceutical Federation (FIP) Board of Pharmaceutical Specialties


4.Li, X. and '''Mansour, H.M.''' ''Physicochemical Characterization and Water Vapor Sorption of Advanced Spray Dried Trehalose Microparticles and Nanoparticles in the Solid-State for Targeted Pulmonary Delivery as Dry Powders.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
11.European Respiratory Society (ERS)


5.Li, X., Hayes, D. Jr., and '''Mansour, H.M.''' ''Comparison of Advanced Spray Dried Micro/Nanoparticulate Aerosols of Antibiotics, Tobramycin and Azithromycin, in the Solid-State for Cystic Fibrosis Treatment: I. Manufacture and Characterization.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
12.International Society for Aerosols in Medicine (ISAM)


6.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Advanced Spray Dried Particles for Targeted Pulmonary Delivery in Lung Cancer.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
13.The Aerosol Society (Great Britain)


7.Ma, J., Carlson, S., Saatman, K.E., and '''Mansour, H.M.''' ''Advanced Spray Dried PLGA Particles for Subcutaneous Delivery.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
14.International Association of Colloid and Interface Scientists (IACIS)


8.Park, C.W, Hayes, D. Jr., and '''Mansour, H.M.''' ''Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Particles for Targeted Pulmonary Inhalation Delivery as Dry Powders.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
15.The Biochemical Society


9.Park, C.W, Hayes, D. Jr., and '''Mansour, H.M.''' ''Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Delivery.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
16.British Society for Nanomedicine


10.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Targeted Dry Powder Microparticulate/Nanoparticulate  Pulmonary Delivery in Bronchoalveolar Carcinoma by Therapeutic-Mucolytic Particles.'' [[UK Markey Cancer Research Day 2011]], Lexington, KY (March 2011).
== Honor Societies (Elected Member)==
1. Phi Eta Sigma National Honor Society


11. McKinlay, A., Zou, Y., Millbrandt, T.,  '''Mansour, H.M.''', and Puleo, D.A.  ''Encapsulation of Vancomycin and Ketoprofen in PLGA Microspheres for Treating Bacterial Infection and Inflammation in Joints''.  [[NSF-REU Summer Research Symposium]], University of Kentucky College of Engineering, Lexington, KY.
2. Phi Kappa Phi National Honor Society


12. Duan, J. H., Park, C.W., Oz, H., Silva, S.R., McGarry, R.C., Dziubla, T.D., Moscow, J.A., and '''Mansour, H.M.'''  ''Targeted Pulmonary Inhalation Delivery of Radioprotectant Nanoparticles for Lung Radioprotection and Alveolar Pneumonitis Prevention.'' [[UK Markey Cancer Research Day 2012]], Lexington, KY (May 2012).
3. Golden Key International Honor Society


13. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.'''  ''Characterization and Optimization of Inhalable PEGylated Phospholipid Microparticles and Nanoparticles Containing Paclitaxel for Targeted Dry Powder Pulmonary Delivery.'' [[UK Markey Cancer Research Day 2012]], Lexington, KY (May 2012). '''2nd Place Postdoc Best Poster Award'''
4. Rho Chi Pharmaceutical Honor Society


14. Stocke, N., '''Mansour, H.M.''', and  Hilt, J.Z.  ''PEG-coated Magnetic Nanoparticles for Treatment of Lung Cancer.'' [[UK Markey Cancer Research Day 2012]], Lexington, KY (May 2012).
5. Sigma Xi Scientific Research Honor Society

Revision as of 07:26, 27 March 2015

Shalom Aleichem. Numen Lumen. Sursum. Lux libertas. Carpe Diem.



"The Leading Research University in the American Southwest" "Sursum"

Dr. Heidi M. Mansour
The University of Arizona
College of Pharmacy & The BIO5 Research Institute
1703 E. Mabel St.
Office 434/Lab 435 Skaggs Pharmaceutical Sciences Center
Tucson, AZ 85721-0202.

Email: mansour@pharmacy.arizona.edu
Office Telephone: (520) 626-2768
Lab Telephone:(520) 626-3232

Websites

Research & Education: [1]

Graduate College Faculty Member:[2]

Faculty Member, The BIO5 Research Institute: [3]

Affiliated Faculty Member, Institute of the Environment: [4]

Associate Member [5], NCI Comprehensive Cancer Center: [6]

Google Scholar Publications: [7] PubMed Publications: [8] LinkedIn Profile: [9] Research Gate Profile: [10]

College of Pharmacy: http://www.pharmacy.arizona.edu/visitors/college-of-pharmacy-facts

World Rankings in Pharmacy & Pharmacology (Global): http://www.topuniversities.com/university-rankings/university-subject-rankings/2014/pharmacy#sorting=rank+region=+country=+faculty=+stars=false+search=

World Rankings in Pharmacy & Pharmacology (USA):http://www.topuniversities.com/university-rankings/university-subject-rankings/2014/pharmacy#sorting=rank+region=+country=257+faculty=+stars=false+search=

The University of Arizona: http://www.arizona.edu/about/highlights-rankings

The University of Arizona Medical Center: http://uanews.org/story/university-of-arizona-medical-center-again-a-u-s-news-best-hospital

Professor Mansour Links

1. University of Wisconsin-Madison, Dept. of Hebrew & Semitic Studies: [11] [12]

2. Tel Aviv University: [13] [14]

3. Harvard Medical School: [15]

4. Stanford University School of Medicine, Molecular Pharmacology: [16] [17]

5. Emory University School of Medicine: [18]

6. University of Texas Southwestern Medical Center: [19]

7. Case Western Reserve University School of Engineering: [20]

8. University of Colorado-Denver:[21][22]

9.University of Utah, Dept. of Molecular Biology & Human Genetics: [23] [24]

10.The University of Texas: [25]

Education

Postdoctorate, University of North Carolina-Chapel Hill[26], School of Pharmacy[27], 1/2006-6/2008.

Postdoctorate, University of Wisconsin-Madison[28], School of Pharmacy[29][30], 2004.

Ph.D. Major-Pharmaceutical Sciences (Pharmaceutics & Drug Delivery), University of Wisconsin-Madison, School of Pharmacy, 12/2003.
Ph.D. Minor-Advanced Physical & Biophysical Interfacial Chemistry, University of Wisconsin-Madison, Department of Chemistry, 12/1999.

B.S.-Pharmacy (Distinction & Honors), University of Wisconsin-Madison, 5/1996.

Health Professional Licensure

Registered Pharmacist 8/1996-Present.

Research Program

Research in the Mansour lab focuses on the fundamental and applied aspects of surface and interfacial chemistry, nanotechnology, and particle engineering technologies in the design and optimization of advanced drug delivery systems. Multifunctional polymeric phospholipid (lipopolymeric) self-assemblies are optimized for targeted drug delivery, nanomedicine, and multifunctional microparticles and nanoparticles in the solid-state as dry powder inhalation aerosols in the targeted treatment and prevention of several pulmonary diseases. These microparticulate/nanoparticulate dry powders which are targeted directly to the lung as dry powder inhalers are biocompatible, biodegradable, mucopenetrating, and provide sustained drug release. We utilize various types of inhaler devices for both in vitro and in vivo rodent animal models. A systematic Quality-by-Design (QbD) approach in the solid-state is used and includes comprehensive physicochemical characterization, design of experiments (DOEs), performance modeling, and prediction. Pulmonary diseases with unmet medical needs that we investigate in vitro and in vivo include lung transplantation, lung cancer, infectious diseases, lung inflammatory fibrotic diseases, and autoimmune diseases. Our research program includes translational medicine, as exemplified by several successful collaborations with physician-scientists.

Editorial Advisory Board Member (EAB)& Scientific Advisor

1. Pharmaceutical Technology North America[31]

2. Recent Patents on Nanomedicine [32]

3. Journal of Pharmaceutical Technology & Drug Research (United Kingdom) [33]

4. Journal of Pharmaceutical Sciences-Scientific Advisor to the Editors [34] [35]

National Expert Committees & Study Sections

1. NIH/NICHD U.S. Pediatric Formulations Initiative (PFI) New Drug Delivery Systems (NDDS) Working Group

2. NIH/NIAID

3. NIH/NCI

4. American Association for the Advancement of Science (AAAS)

International Expert Committees

1. Indo-US Science & Technology

2. Austrian Science Fund

3. German-Israeli Foundation (GIF) for Scientific Research and Development

4. Deutscher Akademischer Austauschdienst Dienst (DAAD)German International Academic Exchange Service

5. Catalent Applied Drug Delivery Institute

Honors & Awards

  • 2010, Mercer School of Pharmacy Dept of Pharmaceutical Sciences, Pharmabeat 2010 Researcher of the Issue, Mercer University
  • 2007-2008, Post Doctoral Fellow Award in Pharmaceutics, PhRMA Foundation
  • 2007-2008, Post Doctoral Scholars Award for Research Excellence, Office of the Vice Chancellor, University of North Carolina at Chapel Hill
  • 2007, Post Doctoral Fellow Award in Research Excellence, American Association of Pharmaceutical Scientists (AAPS)
  • 2001, Walter F. Enz Award in Research Excellence in the Pharmaceutical Sciences, Pharmacia Upjohn Global Pharmaceutical Sciences
  • 2000-2002, PhRMA Advanced Predoctoral Fellow Award in Pharmaceutics, Pharmaceutical Researchers & Manufacturers of America (PhRMA) Foundation
  • 1999-2001, AFPE Predoctoral Fellow Award, American Foundation for Pharmaceutical Education (AFPE)
  • 1996, Merck Award in Excellence in Pharmacy, Merck
  • 1996, Distinction and Honors in Pharmacy, School of Pharmacy, University of Wisconsin-Madison
  • 1994, Academic Excellence Award, Rho Chi Pharmaceutical Honor Society
  • 1993, Sophomore Honors Award, College of Letters and Science, University of Wisconsin-Madison
  • 1992, Chemistry Enrichment Award, Department of Chemistry, University of Wisconsin-Madison
  • 1991-1995, Wisconsin Academic Excellence Award Scholar, Wisconsin Governor & Wisconsin State Legislature
  • 1991, US Presidential Academic Fitness Award Scholar, President of the United States & the United States of America Congress
  • 1991, Elected Member, Phi Eta Sigma National Honor Society
  • 1991, Elected Member, Phi Kappa Phi National Honor Society
  • 1991, Elected Member, Golden Key International Honor Society

Research Support







Invited Speaker (2005-Present)

National and International Invited Speaker Presentations

1.Yale University, Department of Biomedical Engineering, New Haven, CT. 2005.

2.Harvard University, Division of Engineering and Applied Sciences, Cambridge, MA. 2005.

3.UNC-Chapel Hill, Chapel Hill, NC. 2005.

4.10th Annual Liposome Research Days & 1st UNC Drug Conference, Chapel Hill, NC. 2006.

5.American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Phoenix, AZ. Symposium on Phospholipids:"Lipids in Nanotechnology II". Invited Speaker. Presentation Title: “Designed Phospholipid Self-Assemblies in Drug Delivery and Nanomedicine”. 2010. [36]

6.American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Cincinnati, OH. Symposium on “Phospholipids in Pharma and Cosmetics Applications”. Invited Speaker. Presentation Title: "Phospholipid Nanopharmaceuticals in Advanced Drug Delivery". 2011. [37]

7.International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on “Solid-State Transformation During Formulations and Processing”. Invited Speaker. Presentation Title: "Water Vapor-Solid Interactions and Effects on Solid-State Phase Transitions in Engineered Microparticulate/Nanoparticulate Pharmaceutical Powders". 2011.

8. International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on “Imaging of Drugs and Dosage Forms to Better Understand Dissolution”. Invited Speaker. Presentation Title: "Imaging Techniques for Designed Microparticulate/Nanoparticulate Pharmaceutical Powders". 2011.

9. American Chemical Society (ACS) 242nd Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry-Symposium on “Nanomedicine: Colloids & Surface Science”. Denver, CO.

Symposium Session Chair Presider [38]

Invited Symposium SpeakerPresentation Title: "Rational Design, Development, and Optimization of Nanopharmaceuticals for Targeted Drug Delivery in Nanomedicine: An Interfacial and Colloidal Science Approach”. 2011.[39]

10. 4th Annual AAPS Nanotechnology & Nanomedicine Symposium, Louisville, KY. Invited Speaker. Presentation Title: "Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Aerosol Delivery." 2011.

11. Pfizer, Inc., Worldwide Research & Development, Global Headquarters, Groton, CT. Invited Speaker. Presentation Title: "Engineering Particles by Advanced Spray Drying for Drug Delivery." 2011.

12. Center for Pulmonary Research, Children's Hospital Research Institute, The Ohio State University, Columbus, OH. Invited Speaker in the Translational Pulmonary Research Seminar Series. Presentation Title: "Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention." 2012.

13. International Conference & Exhibition on Nanotechnology & Nanomedicine. Omaha, NE. Invited Speaker. Presentation Title: "Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention." 2012.

14.Transcept Pharmaceuticals. Invited Webinar Speaker. Presentation Title: "Fundamental and Applied Aspects of Sustained Release Injectible Depot Delivery". 2012.

15. Buchi Hands-On Spray Drying Course, Buchi U.S. Headquarters. New Castle, DE. Invited Speaker. Presentation Title: "Engineering Particles by Advanced Organic Solution Spray Drying for Nanopharmaceuticals and Targeted Pulmonary Inhalation Aerosol Delivery." 2012. [40]

16. Lovelace Respiratory Research Institute (LRRI). Albuquerque, NM. Invited Speaker in the LRRI and CNTC Seminar Series. Presentation Title:"Advances in Targeted Lung Nanomedicine as Aerosolized Multifunctional Microparticles and Nanoparticles for Pulmonary Disease Treatment and Prevention." 2012. [41]

17. Controlled Release Society (CRS) 39th Annual Meeting & Exhibition. Quebec City, Quebec, Canada. Invited Speaker. CRS Workshop: "Mucosal Drug and Gene Delivery: Barriers and Opportunities." Presentation Title: "Pulmonary Drug Delivery". 2012.[42]

18. 1st International Symposium on Nanomedicine in Drug Delivery and Cancer Diagnosis. University of Delaware, College of Health Sciences, Newark, DE. Organizing Committee Member [43]. Nano Drug Delivery Session Chair Presider [44]. Invited Symposium Speaker in the Nanomedicine Session. Presentation Title: "Advances in Targeted Lung Nanomedicine as Multifunctional Microparticles & Nanoparticles for Targeted Pulmonary Delivery." 2012. [45]

19. Wayne State University Applebaum College of Pharmacy, Department of Pharmaceutical Sciences Seminar Series. Detroit, MI. Invited Speaker. 2012.[46]

20. North American Cystic Fibrosis Conference (NACFC), Orlando, FL. Invited Symposium Speaker. NACFC Aerosol Symposium: "Aerosol Treatments in CF: Clearing the Fog." Presentation Title: "Aerosol Formulation Issues." 2012.[47]

21. 19th World Congress of the International Society of Aerosols in Medicine (ISAM), Chapel Hill, NC. Invited Speaker. ISAM Workshop: "Nanomedicine & Nanotoxicology: Inhaling nanoparticles by accident and on purpose-challenges and opportunities for toxicology and therapeutics." Presentation Title: "Nanotechnology in Dry Powder Inhalation Aerosol Formulations." 2013.[48]

22. AAPS/USP/FDA/IPAC Workshop on Inhaled Drug Products, United States Pharmacopeia (USP), Rockville, MD. Invited Speaker. "Inhaled Drug Products: Current Practices and the Future of In Vitro Testing Technologies and Regulation." Presentation Title: "Solid-State Characterization and Nanotechnology in Inhalation Aerosol Formulation Development." 2013. [49]

23. Association of Inhalation Toxicologists (AIT) Annual Conference, Hannover, Germany. Invited Speaker. Session: "Nanomaterials." Presentation Title: "Nanomaterials as an Aerosol Formulation Carrier in Inhalation Aerosol Nanomedicine." 2013. [50]

24. Eastern Analytical Symposium & Exhibition (EAS), Somerset, NJ. Invited Speaker. Coblentz EAS Session: "Spectroscopic Applications in Biologics." Presentation Title:"Characterization and Spectroscopic Applications in Pulmonary Delivery and Advanced Dry Powder Inhalers." 2013. [51] [52]

25.Buchi Hands-On Spray Drying Course, Newark, DE. Invited Speaker Presentation: "Designing High Performing Microparticulate/Nanoparticulate Dry Powder Inhalers by Organic Solution Advanced Spray Drying." 2014. [53]

26.American Chemical Society (ACS) 249th Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry Symposium, Denver, CO. Invited Symposium Presentation: "Advances in Targeted Multifunctional Inhalation Aerosols with Nanotechnology and Solid-State Particle Engineering Design." 2015.

27. American Thoracic Society (ATS) International Conference joint with ISAM, Denver, CO. ATS/ISAM Presentation: "Multifunctional Nanotechnology in Lung Surfactant-Mimic Inhalation Aerosols as High-Performing Dry Powder Inhalers for Targeted Pulmonary Medicine." 2015.

28. Inhalation Magazine Annual Webinar joint with CSC Publishing and MSP Corporation. Invited Presentation: "Inhalation Pharmaceuticals: Device Design and Formulations." 2015.

29. Controlled Release Society (CRS) 42nd Annual Meeting & Exhibition. Edinburgh, Scotland, Great Britain. CRS Workshop Co-Chair & Invited Speaker. CRS Workshop: "Advanced Pulmonary Drug Delivery: From Generating Aerosols to Overcoming Biological Barriers." 2015.[54]

30. Antibiotic resistance and antibiotic alternatives: Looking towards the future, London, England. Invited Speaker Presentation: "Targeted Pulmonary Delivery of Antibiotics by Multifunctional Dry Powder Inhalation Aerosols and Nanotechnology for Pulmonary Infectious Diseases." 2015. [55]

Short-Course/Workshop Instructor

1.Aerosol School 2-Day Workshop: "Aerosol Science Fundamentals and Inhalation Aerosol Delivery", NIH-NCI Cancer Nanotechnology Training Center (CNTC), April 17-18 2012.

Journal Publications

== 2001-2009 ==

1. Mansour H., Wang D.-S., Chen C.-S., and Zografi G. Comparison of Bilayer and Monolayer Properties of Phospholipid Systems Containing Dipalmitoylphosphatidylglycerol and Dipalmitoylphosphatidylinositol. Langmuir (2001) 17 (21) October 16: 6622-6632. (Impact Factor: 4.384)[56]

2. Mansour, H.M. and Zografi G. The Relationship Between Water Vapor Absorption and Desorption by Phospholipids and Bilayer Phase Transitions. Journal of Pharmaceutical Sciences (2007) 96 (2) February: 377-396. (Impact Factor: 3.007)[57]

3. Mansour, H.M. and Zografi G. Relationships Between Equilibrium Spreading Pressure and Phase Equilibria of Phospholipid Bilayers and Monolayers at the Air-Water Interface. Langmuir (2007) 23 (7) March 27: 3809-3819. (Impact Factor: 4.384)[58]

4. Hickey, A.J., Mansour, H.M., et al. Physical Characterization of Component Particles Included in Dry Powder Inhalers: I. Strategy Review and Static Characteristics. Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue (2007) 96 (5) May: 1282-1301. (Impact Factor: 3.007)[59]

5. Hickey, A.J., Mansour, H.M., et al. Physical Characterization of Component Particles Included in Dry Powder Inhalers: II. Dynamic Characteristics. Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue (2007) 96 (5) May: 1302-1319. (Impact Factor: 3.007)[60]

6. Mansour, H.M. and Hickey, A.J. Raman Characterization and Chemical Imaging of Biocolloidal Self-Assemblies, Drug Delivery Systems, and Pulmonary Inhalation Aerosols. A Review. AAPS PharmSciTech (2007) 8 (4) November 30: Article 99:E1-E16. (Impact Factor: 1.776)[61]

7. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. Comparative Dispersion Study of Dry Powder Aerosols of Albuterol Sulfate/Lactose Monohydrate and Cromolyn Sodium/Lactose Monohydrate Delivered by Standardized Entrainment Tubes. Respiratory Drug Delivery (2008) 3: 897-900. [62]

8. Mansour H.M., Damodaran S., and Zografi G. Characterization of the In Situ Structural and Interfacial Properties of the Cationic Hydrophobic Heteropolypeptide, KL4, in Lung Surfactant Bilayer and Monolayer Models at the Air-Water Interface: Implications for Pulmonary Surfactant Delivery. Molecular Pharmaceutics (2008) 5 (5) October 6: 681-695. (Impact Factor: 4.787)[63]

9. Mansour, H.M., Rhee, Y.S., and Wu, X. Nanomedicine in Pulmonary Delivery. International Journal of Nanomedicine (2009) 4 December: 299-319.(Impact Factor: 4.195)[64]


== 2010 ==

10. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 1. Albuterol Sulfate and Disodium Cromoglycate. Journal of Pharmaceutical Sciences (2010) 99 (8) March 2: 3398-3414.(Impact Factor: 3.007)[65]

11. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate. Journal of Pharmaceutical Sciences (2010) 99 (8) March 10: 3415-3429. (Impact Factor: 3.007)[66]

12. Mansour, H.M., Xu, Z., and Hickey, A.J. Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Alternative Sugar Blends: 3. Trehalose Dihydrate and D-Mannitol Carriers. Journal of Pharmaceutical Sciences (2010) 99 (8) March12; 3430-3441.(Impact Factor: 3.007)[67]

13. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. Heterogenous Particle Deaggregation and Its Implications for Therapeutic Aerosol Performance. Journal of Pharmaceutical Sciences (2010) 99 (8) March 15: 3442-3461.(Impact Factor: 3.007)[68]

14. Mansour, H.M., Sohn, M., Al-Ghananeem, A., and DeLuca P.P. Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects. Invited Paper. International Journal of Molecular Sciences: Special Issue-Material Sciences and Nanotechnology Section - Biodegradability of Materials in Biomedical Applications. (2010) 11: 3298-3322. (Impact Factor: 2.339)[69]

15. Rhee, Y.S., Park, C.W., DeLuca, P.P., and Mansour, H.M. Sustained-Release Injectable Drug Delivery Systems. An Invited Paper. Pharmaceutical Technology: Special Issue-Drug Delivery (2010) November: 6-13. [70]

16. Hayes, D. Jr., Zwischenberger, J.B., and Mansour, H.M. Aerosolized Tacrolimus: A Case Report in a Lung Transplant Recipient. Transplantation Proceedings (2010) 42 (9) November: 3876-3879.(Impact Factor: 1.061) [71]

17. Wu, X., Li, X., and Mansour, H.M. Surface Analytical Techniques in Solid-State Particle Characterization: Implications for Predicting Performance in Dry Powder Inhalers. Invited Paper. KONA Powder and Particle Journal (2010) 28: 3-19/ (Impact Factor: 1.227) full text[72] [73]


== 2011 ==

18. Xu, Z., Mansour, H.M., and Hickey, A.J. Particle Interactions in Dry Powder Inhaler Unit Processes. Journal of Adhesion Science and Technology: Special Issue on Adhesion Aspects in Pharmaceutical Sciences (2011): 25 (4/5) 451-482. (Impact Factor: 1.175)[74]

19. Rhee, Y.S. and Mansour, H.M. Nanopharmaceuticals I: Nanocarrier Systems in Drug Delivery. Invited Paper. International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals. (2011) 8 (1/2): 84-114.(Impact Factor: 1.144)[75]

20. Wu, X. and Mansour, H.M. Nanopharmaceuticals II: Application of Nanoparticles and Nanocarrier Systems in Pharmaceutics and Nanomedicine. Invited Paper. International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals. (2011) 8 (1/2): 115-145. (Impact Factor: 1.144)[76]

21. Wu, X.,and Mansour, H.M. Pulmonary and Nasal Anti-Inflammatory and Anti-Allergy Inhalation Aerosol Delivery Systems. Invited Paper. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry: Special Issue-Optimizing a Therapeutic with Anti-Inflammatory Agents: Novel Drug Delivery Systems. (2011)10 (3): 215-229. [77]

22. Park, C.W., Hayes, D. Jr., and Mansour, H.M. Pulmonary Inhalation Aerosols for Targeted Antibiotics Drug Delivery. Invited Paper & Cover Page. European Pharmaceutical Review. (2011) 16 (1): 32-36.[78]

23. Mansour, H.M. Molecular Forces and Self Assembly in Colloid, Nano Sciences and Biology. Invited Paper. Journal of the American Chemical Society. (2011) 133 (13): 5162. (Impact Factor: 9.907) [79]

24. Hayes, D. Jr and Mansour, H.M. Improved Outcomes of Patients with End-Stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure. Lung. (2011) 189 (5): 409-415. (Impact Factor: 2.171)[80] [81]

25. Hayes, D. Jr., Ball, A.M., Mansour, H.M., Martin, C.A.,and Flynn, J.D. Fungal Infection in Heart-Lung Transplant Recipients Receiving Single-agent Prophylaxis With Itraconazole. Experimental and Clinical Transplantation (2011)9 (6): 399-404. [82].

26. Rhee, Y.S., Sohn, M., Woo, B.H., Thanoo, B.C., DeLuca, P.P., and Mansour, H.M. Sustained-Release Delivery of Octreotide from Biodegradable Polymeric Microspheres. AAPS PharmSciTech: Special Theme Issue-Sterile Products: Advances and Challenges in Formulation, Manufacturing, Devices and Regulatory Aspects.(2011)12 (4):1293-1301. (Impact Factor: 1.776)[83] [84]

27. Li, X. and Mansour, H.M. Physicochemical Characterization and Water Vapor Absorption of Organic Solution Advanced Spray Dried Trehalose Microparticles and Nanoparticles for Targeted Dry Powder Pulmonary Inhalation Delivery. AAPS PharmSciTech: Special Theme Issue: Advances in Pharmaceutical Excipients Research and Use: Novel Materials, Functionalities and Testing (2011)12(4):1420-1430. (Impact Factor: 1.776)[85] [86]


== 2012 ==

28. Hayes, D. Jr., Winkler, M.A., Kirkby, S., Capasso, P., Mansour, H.M. and Attili, A.K. Preprocedural Planning with Prospectively Triggered Multi-Detector Row CT Angiography prior to Bronchial Artery Embolization in Cystic Fibrosis Patients with Massive Hemoptysis. Lung (2012)190 (2)April:221-225.(Impact Factor: 2.171)[87]

29. Hayes, D. Jr. and Mansour, H.M. Vanishing Bronchus Intermedius Syndrome in a Pediatric Patient with Cystic Fibrosis After Lung Transplantation. Pediatric Transplantation: The Official Journal of the International Pediatric Transplant Association (2012)16(8):333-337. [Impact Factor: 1.630][88]

30. Hayes, D. Jr., Mansour, H.M., Kirkby, S., and Phillips, A.B. Rapid Acute Onset of Bronchiolitis Obliterans Syndrome in a Lung Transplant Recipient After Respiratory Syncytial Virus Infection." Transplant Infectious Diseases (2012)14 (5): 548-550. [Impact Factor: 2.25][89]

31. Duan, J.H., Mansour, H.M., Zhang, Y.D., Deng, X.M., Zhao, J.F. Reversion of Multi-Drug Resistance by Co-Encapsulation of Doxorubicin and Curcumin in Chitosan/poly(butylcyanoacrylate) Nanoparticles. International Journal of Pharmaceutics (2012) 426 (1-2): 193-201. (Impact Factor: 3.785)[90]

32. Park, C.W., Mansour, H.M., Oh, T.O., Kim, J.Y., Ha, J.M., Lee, B.J., Chi, S.C., Rhee, Y.S., Park, E,S. "Phase behavior of itraconazole-phenol mixtures and its pharmaceutical applications." International Journal of Pharmaceutics (2012) 436 (1-2):652-658.(Impact Factor: 3.785) [91]

33. Park, C.W., Rhee, Y.S., Vogt, F.G., Hayes, D Jr., Zwischenberger, J.B., DeLuca, P.P., and Mansour, H.M. Advances in Microscopy and Complementary Imaging Techniques to Assess the Fate of Drugs Ex-Vivo in Respiratory Drug Delivery. Invited Paper. Advanced Drug Delivery Reviews: Special Theme Issue-Computational and Visualization Approaches in Respiratory Delivery. (2012) 64 (4) March 30: 344-356. (Impact Factor: 12.707)[92]

34. Willis, M.L., Hayes, D Jr., and Mansour, H.M. Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery. Lung (2012) 190 (3): 251-262.(Impact Factor: 2.171)[93] [94]

35.Mansour, H.M. "Aerosol Formulation Issues." Pediatric Pulmonology (2012) 47 (35):149-151. (Impact Factor: 2.297) [95]


== 2013 ==

36. Meenach, S.A. Vogt,F.G., Anderson, K.W., Hilt, J.Z., McGarry,R.C., and Mansour, H.M.. Design, Physicochemical Characterization, and Optimization of Organic Solution Advanced Spray-Dried Inhalable Dipalmitoylphosphatidylcholine (DPPC) and Dipalmitoylphosphatidylethanolamine Poly(Ethylene Glycol) (DPPE-PEG) Microparticles and Nanoparticles for Targeted Respiratory Nanomedicine Delivery as Dry Powder Inhalation Aerosols. International Journal of Nanomedicine (2013) 8:275-293.(Impact Factor: 4.195)[96]

37. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and Mansour, H.M. Characterization and Aerosol Dispersion Performance of Advanced Spray-Dried Chemotherapeutic PEGylated Phospholipid Particles for Dry Powder Inhalation Delivery in Lung Cancer. European Journal of Pharmaceutical Sciences (2013) 49 (4): 699-711.(Impact Factor: 3.005)[97]

38. Wu,X., Hayes, D Jr., Zwischenberger, J.B., Kuhn, R.J., and Mansour, H.M. Design and Physicochemical Characterization of Advanced Spray-Dried Tacrolimus Multifunctional Particles for Inhalation. Drug Design, Development, and Therapy (2013) 7:59-72. (Impact Factor: 3.026) [98]

39. Wu,X., Zhang, W., Hayes, D Jr., and Mansour, H.M. Physicochemical Characterization and Aerosol Dispersion Performance of Organic Solution Advanced Spray-Dried Cyclosporine A Multifunctional Particles for Dry Powder Inhalation Aerosol Delivery. International Journal of Nanomedicine (2013) 8 :1269-1283.(Impact Factor: 4.195)[99]

40. Park, C.W., Li X., Vogt, F.G., Hayes, D. Jr., Zwischenberger, J.B., Park, E.S. and Mansour, H.M. Advanced Spray Dried Design, Physicochemical Characterization and Aerosol Dispersion Performance of Vancomycin and Clarithromycin Multifunctional Controlled Release Particles for Targeted Respiratory Delivery as Dry Powder Inhalation Aerosols.. International Journal of Pharmaceutics (2013) 455 (1–2): 374–392.(Impact Factor: 3.785)[100]

41. Zheng Z, Zhang W, Sun W, Li X, Duan J, Cui J, Feng Z, and Mansour, H.M. Influence of the Carboxymethyl Chitosan Anti-Adhesion Solution on the TGF-β1 in a Postoperative Peritoneal Adhesion Rat. Journal of Materials Science: Materials in Medicine (2013) 24 (11): 2549-2559. (Impact Factor: 2.379) [101]

42. Duan J.H., Vogt, F.G., Li X., Hayes, D. Jr., and Mansour, H.M. Design, Physicochemical Characterization and Aerosolization of Organic Solution Advanced Spray Dried and Co-Spray Dried Moxifloxacin and Ofloxacin Dipalmitoylphosphatidylcholine (DPPC) Microparticulate/Nanoparticulate Powders for Pulmonary Inhalation Aerosol Delivery. International Journal of Nanomedicine (2013) 8: 3489-3505. [102](Impact Factor: 4.195)

43. Hayes, D. Jr., Galantowicz, M., Yates, A.R., Preston, T.J., Mansour, H.M., and McConnell, P.I. Venovenous ECMO as a Bridge to Lung Transplant and Protective Strategy for Subsequent Primary Graft Dysfunction. Journal of Artificial Organs (2013) 16 (3): 382-385. (Impact Factor: 1.60)[103]

44. Hayes, D. Jr., Baker, P.B., Mansour, H.M., Peeples, M.E., and Nicol, K.K. Interstitial Lung Disease in a Child with Antisynthetase Syndrome. Lung (2013) 191 (4): 441-443. (Impact Factor: 2.171)[104]

45.Hayes, D. Jr., Daniels, C.J., Mansour, H.M., Kopp, B.T., Yates, A.R., McCoy, K.S., Patel, A.V., and Kirby, S. Right Heart Catherization Measuring Central Hemodynamics in Cystic Fibrosis During Exercise. Respiratory Medicine (2013): 107 (9): 1365–1369. [Impact Factor: 2.917][105]

46. Hayes, D. Jr., Daniels, C.J., Mansour, H.M., Kopp, B.T., Yates, A.R., Preston, T., and Kirby, S. Identification of the Nodose Ganglia and TRPV1 in Swine. Lung (2013): 191(5):445-447(Impact Factor: 2.171)[106]

47.Hayes, D Jr., Kirkby, S., McCoy, K.S., Mansour, H.M., Khosravi, M., Strawbridge, H., and Tobias, J.D. Reduction of Lipid-Laden Macrophage Index After Laproscopic Nissen Fundoplication in Cystic Fibrosis Patients After Lung Transplantation. Clinical Transplantation (2013) 27 (1): 121-125.(Impact Factor: 1.486) [107]


== 2014 ==

48. Hayes, D. Jr., Yates, A.R., Duffy, V., Tobias, J., Mansour, H.M., Olshove, V., and Preston, T.J. Rapid placement of bicaval dual-lumen catheter in a swine model of venovenous ECMO. Journal of Investigative Surgery (2014): 27(1):27-31. [Impact Factor: 1.316] [108]

49. Hayes, D. Jr., Adler, B., Turner, T.L., and Mansour, H.M.. Alternative Tacrolimus and Sirolimus Regimen Associated with Rapid Resolution of Posterior Reversible Encephalopathy Syndrome After Lung Transplantation. Pediatric Neurology (2014) 50: 272-275.(Impact Factor: 1.504)[109]

50. Li X., Vogt, F.G., Hayes, D. Jr., and Mansour, H.M. Physicochemical Characterization and Aerosol Dispersion Performance of Organic Solution Advanced Spray Dried Microparticulate/Nanoparticulate Antibiotic Dry Powders of Tobramycin and Azithromycin for Pulmonary Inhalation Aerosol Delivery. European Journal of Pharmaceutical Sciences (2014) 15: 191-205. (Impact Factor: 3.005) [110]

51.Li X., Vogt, F.G., Hayes, D. Jr., and Mansour, H.M. Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Spray-Dried Microparticulate/Nanoparticulate Mannitol Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers. Journal of Aerosol Medicine & Pulmonary Drug Delivery (2014): 27 (2):81-93. (Impact Factor: 2.395)[111]

52. Li X., Vogt, F.G., Hayes, D. Jr., and Mansour, H.M. Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Co-Spray Dried Antibiotics with Mannitol as Respirable Microparticles/Nanoparticles for Targeted Pulmonary Delivery as Dry Powder Inhalers. Journal of Pharmaceutical Sciences: George Zografi Dedicated Issue (2014)103(9): 2937-2949. [Impact Factor: 3.007][112]

53. Muralidharan, P., Mallory, E., Malapit, M., Hayes, D. Jr., and Mansour, H.M. Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Pharmaceutics: Special Issue: Liposomal Technologies (Guest Editor: Prof. Timothy D. Heath, UW-Madison) (2014) 6 (2): 333-353. [113] [114]

54. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and Mansour, H.M. High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies. AAPS PharmSciTech: Theme Issue on Advances in Formulation and Device Technologies in Pulmonary Drug Delivery (2014)15(6) December:1574-1587. [Impact Factor: 1.776] [115] [116]

55. Hayes, D. Jr., Tobias, J.D., Mansour, H.M., Kirkby, S., McCoy, K.S., Daniels, C.J., and Whitson, B.A. Pulmonary Hypertension in Cystic Fibrosis with Advanced Lung Disease. American Journal of Respiratory and Critical Care Medicine (2014) 190 (8):898-905. [Impact Factor: 11.986] [117]
“F1000Prime Recommended by F1000Respiratory Disorders Faculty” [118]


== 2015 ==

56. Stocke, N., Meenach, S.A.,Arnold, S.M., Mansour, H.M.*,and Hilt, J.Z. Formulation and Characterization of Inhalable Magnetic Nanocomposite Microparticles (MnMs) for Targeted Pulmonary Delivery via Spray Drying. International Journal of Pharmaceutics (2015) 479 (2): 320–328. *Corresponding Authors [Impact Factor: 3.785] [119]

57. Hayes, D. Jr., McCoy, K.S., Whitson, B.A., Mansour, H.M. , and Tobias, J.D. High-Risk Age Window for Mortality in Children with Cystic Fibrosis after Lung Transplantation. Pediatric Transplantation (2015)19(2):206-210.(Impact Factor: 1.63)[120]

58. Hayes, D. Jr., Black, S.M., Tobias, J.D., Mansour, H.M., and Whitson, B.A. Influence of pulmonary hypertension on survival in advanced lung disease. Lung (2015)193(2):213-21. [Impact Factor: 2.171][121]

59. Hayes, D. Jr., Black, S.M., Tobias, J.D., Mansour, H.M., and Whitson, B.A. Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation. COPD: Journal Of Chronic Obstructive Pulmonary Disease (IN PRESS) [Impact Factor: 2.620]

60. Muralidharan, P., Hayes, D. Jr., and Mansour, H.M. Dry Powder Inhalers in COPD, Lung Inflammation, and Pulmonary Infections. Expert Opinion on Drug Delivery: Theme Issue on Drug Delivery to the Lungs (2015) 1-16. (Impact Factor: 4.116)[122]

61. Muralidharan, P., Malapit, M., Mallory, E., Hayes, D. Jr., and Mansour, H.M. Inhalable Nanoparticulate Powders for Respiratory Delivery. Invited Paper. Nanomedicine: Nanotechnology, Biology, and Medicine (2015)IN PRESS. [Impact Factor: 5.978][123][124]

Edited Book (co-Editor)

1. Nanomedicine in Drug Delivery, Kumar, A., Mansour, H.M., Friedman, A., and Blough, E. (Editors), CRC Press/Taylor & Francis, London, United Kingdom. (2013) 469 pages. ISBN: 9781466506169 [125][126][127]

Book Chapters

1. Hickey, A.J. and Mansour, H.M. Book Volume 2, Book Chapter 43: Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols. Modified-Release Drug Delivery Technology, Drugs and the Pharmaceutical Sciences Series.728 pages. Rathbone, M. J., Hadgraft, J., Roberts, M.S., Lane, M.E, (Editors), Second Edition, Informa Healthcare, New York, (2008): pp. 573-602. ISBN: 9781420053555 [128]

2. Hickey, A.J. and Mansour, H.M. Book Volume 2, Book Chapter 5: Delivery of Drugs by the Pulmonary Route. Modern Pharmaceutics Volume 2: Applications and Advances, Drugs and the Pharmaceutical Sciences Series,.500 pages. Florence, A.T., Siepmann, J. (Editors), Fifth Edition, Informa Healthcare, New York, (2009): 191-219. ISBN: 9781420065664 [129]

3. Mansour, H.M., Rhee, Y.S., Park, C.W., and DeLuca, P.P. Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine. Lipids in Nanotechnology. 306 pages. Moghis, A. (Editor), American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2012): pp.221-268.ISBN: 9780981893679 [130]

4. Mansour, H.M., Park, C.W., and Hayes, D. Jr. Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine. Nanomedicine in Drug Delivery. 469 pages. Kumar, A., Mansour, H.M., Friedman, A., Blough, E. (Editors), CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. ISBN: 9781466506169 [131] [132][133]

5. Mansour, H.M. and Park, C.W. Book Chapter 7: Therapeutic Applications and Targeted Delivery of Nanomedicines and Nanopharmaceutical Products. The Clinical Nanomedicine Handbook. 365 pages. Brenner, S.A. (Editor), CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.321-338. ISBN: 9781439834787 [134]

6. Mansour, H.M., Xu, Z., Meenach, S.A., Park, C.W., Rhee, Y.S., and DeLuca, P.P. Book Chapter 5: Novel Drug Delivery Systems. Drug Delivery. 550 pages. Mitra, A.K. (Editor), Jones & Bartlett, Burlington, MA. (2015): pp.71-107. ISBN-13: 9781284025682 [135]

7. Mansour, H.M., Park, C.W., and Bawa, R. Book Chapter 9: Design and Development of Approved Nanopharmaceutical Products. Handbook of Clinical Nanomedicine: From Bench to Bedside. 1000+ pages. Bawa,R., Audette, G., and Rubinstein, I. (Editors), Pan Stanford Publishing, Singapore. (2015): pp.1-40. ISBN: 9789814316170 [136] [137]

8. Mansour, H.M., Muralidharan, P., and Hayes, D. Jr. Book Chapter 8b: Inhaled Nanoparticulate Systems: Composition, Manufacture, and Aerosol Delivery. The ISAM Textbook of Aerosol Medicine. Dhand, R. (Editor-in-Chief), Rothen-Rutishauser, B., and Hickey A.J. (Associate Editors), International Society of Aerosols in Medicine (ISAM)/Mary Ann Libert Publishing, Inc. Rochelle, NY. (2015).

9. Mansour, H.M., Myrdal, P.B., Younis, U., Muralidharan, P., and Hayes, D. Jr. Book Chapter 12: Pulmonary Drug Delivery. Drug Delivery & Targeting. Hillery, A.M., Swarbrick, J., and Park, K., (Editors), Second Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2015)

Professional Memberships

1.Academy of Pharmaceutical Sciences of Great Britain (APSGB)

2.American Thoracic Society (ATS)

3.American Pharmacists Association (APhA)[138]

4.American Chemical Society (ACS)

5.American Association of Pharmaceutical Scientists (AAPS)

6.American Association of the Colleges of Pharmacy (AACP)

7.American Society for Nanomedicine (ASNM)

8.Controlled Release Society (CRS)

9.European Federation for Pharmaceutical Sciences (EUFPS)

10.International Pharmaceutical Federation (FIP) Board of Pharmaceutical Specialties

11.European Respiratory Society (ERS)

12.International Society for Aerosols in Medicine (ISAM)

13.The Aerosol Society (Great Britain)

14.International Association of Colloid and Interface Scientists (IACIS)

15.The Biochemical Society

16.British Society for Nanomedicine

Honor Societies (Elected Member)

1. Phi Eta Sigma National Honor Society

2. Phi Kappa Phi National Honor Society

3. Golden Key International Honor Society

4. Rho Chi Pharmaceutical Honor Society

5. Sigma Xi Scientific Research Honor Society

Retrieved from "https://openwetware.org/mediawiki/index.php?title=Dr.HeidiM.Mansour&oldid=875707"